Processing 00000000.tx.1: A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease Jean-Charles Lambert1, Florence Pasquier2, Dominique Cottel1, Bernard Frigard3, Philippe Amouyel1,*, Marie-Christine Chartier-Harlin1 1INSERM CJF95-05, Institut Pasteur de Lille, 1 rue du Professeur Calmette, 59019 Lille Cedex, France, 2CHR et U de Lille, Clinique Neurologique, Centre de la Mmoire, Hpital Salengro, 59037 Lille cedex, France and 3Centre de Griartrie de Wasquehal Molinel, rue Salvador Allende, B.P. 

Phrase: "A new polymorphism in the APOE promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0678951:gene polymorphism [Genetic Function]
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk of developing Alzheimer's Disease Jean-Charles Lambert1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0243083:associated disease [Pathologic Function]
   757   C1281905:disease risk [Finding]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0035647:Risk [Qualitative Concept]
   739   C0453932:jean [Manufactured Object]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "Florence Pasquier2,"

Phrase: "Dominique Cottel1,"

Phrase: "Bernard Frigard3,"

Phrase: "Philippe Amouyel1,"

Phrase: "*,"

Phrase: "Marie-Christine Chartier-Harlin1 1INSERM CJF95-05,"

Phrase: "Institut Pasteur de Lille,"

Phrase: "1 rue du Professeur Calmette,"

Phrase: "59019 Lille Cedex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0591239:Cedex [Antibiotic,Organic Chemical]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2CHR et U de Lille,"

Phrase: "Clinique Neurologique,"

Phrase: "Centre de la Mmoire,"

Phrase: "Hpital Salengro,"

Phrase: "59037 Lille cedex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0591239:Cedex [Antibiotic,Organic Chemical]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "3Centre de Griartrie de Wasquehal Molinel,"

Phrase: "rue Salvador Allende,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2760314:Allende [Eukaryote]

Phrase: "B.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.2: 165, 59444 Wasquehal, France Received October 28, 1997; 

Phrase: "165,"

Phrase: "59444 Wasquehal,"

Phrase: "France Received October 28,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016674:France [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.3: Revised and Accepted December 19, 1997 The [epsis]4 allele of the Apolipoprotein E gene (APOE), one of the main allele of APOE polymorphism, is a major risk factor for the development of Alzheimer's disease. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted December 19,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1997"

Phrase: "The [epsis"

Phrase: "]4 allele of the Apolipoprotein E gene (APOE),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "one of the main allele of APOE polymorphism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "a major risk factor for the development of Alzheimer's disease."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   795   C0850664:risk factor (of) disease [Finding]
           disease risk factor
   760   C0035648:Risk factor [Quantitative Concept]
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0679238:disease factor [Functional Concept]
   757   C0960756:factor A [Organic Chemical]
   757   C1281905:disease risk [Finding]
   739   C0035647:Risk [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.4: However, several data suggest that genetic factors, within the APOE locus, may also modulate the risk associated with this polymorphism. 

Phrase: "However,"

Phrase: "several data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that genetic factors,"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "within the APOE locus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1708726:Gene Locus [Gene or Genome]
           Locus
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with this polymorphism."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0032529:Polymorphism [Genetic Function]
   770   C1882417:Polymorphism [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.5: We look for new mutations in the APOE promoter, susceptible to modify the risk associated with the APOE [epsis]4 allele. 

Phrase: "We"

Phrase: "look for new mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C2985439:new mutation [Cell or Molecular Dysfunction]
   770   C0026882:Mutations [Genetic Function]
   770   C0205314:New [Temporal Concept]
   770   C0233426:look [Organism Attribute]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the APOE promoter,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "susceptible to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231204:Susceptible [Functional Concept]
   861   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the APOE"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1412481:Apolipoprotein E gene [Gene or Genome]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C1445865:Apolipoprotein gene [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[epsis"

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.6: We characterised a G[rarr]T mutation at -186 bp of the APOE gene TATA box, named Th1/E47cs. 

Phrase: "We"

Phrase: "characterised"

Phrase: "a G[rarr"

Phrase: "]T mutation at -186 bp"

Phrase: "of the APOE gene TATA box,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0080206:TATA Box [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0179400:Box [Manufactured Object]
   799   C1533124:Box [Medical Device]

Phrase: "named Th1/E47cs."
Processing 00000000.tx.7: This new polymorphism is located in a consensus sequence of a potential transcriptional (Th1/E47) factor binding site. 

Phrase: "This new polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "located in a consensus sequence of a potential transcriptional"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0079160:Consensus Sequence [Nucleotide Sequence]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0040649:Transcriptional [Genetic Function]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0376298:Consensus [Social Behavior]
   742   C1519249:Sequence [Functional Concept]
   742   C3245505:Potential [Qualitative Concept]

Phrase: "(Th1/E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: ")"

Phrase: "factor binding site."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.8: We studied the impact of this new polymorphism with those of other markers of the APOE locus in a large case-control study and observed that Th1/E47cs modulated the influence of the APOE [epsis]4 allele on the risk of Alzheimer's disease. 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the impact of this new polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "with those"

Phrase: "of other markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "of the APOE locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1708726:Gene Locus [Gene or Genome]
           Locus
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "in a large case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0007328:Case-Control Study [Research Activity]
   875   C0085973:Case Study [Intellectual Product]
   861   C0872128:case control [Health Care Activity]
   812   C0243148:control [Qualitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0868928:Case [Functional Concept]
   812   C1550141:Control [Substance]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C2603343:Study [Research Activity]
   812   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that Th1/E47cs"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "the influence of the APOE"

Phrase: "[epsis"

Phrase: "]4 allele on the risk of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.9: INTRODUCTION The apolipoprotein E gene (APOE), a key player of the lipid transport, exists as three main alleles in the general population: [epsis]2, [epsis]3 and [epsis]4. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The apolipoprotein E gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "a key player of the lipid transport,"

Phrase: "exists as three main alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002085:Alleles [Gene or Genome]
   760   C0205225:Main [Qualitative Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1542147:Main [Qualitative Concept]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "in the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: ":"

Phrase: "[epsis"

Phrase: "]2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4."
Processing 00000000.tx.10: These polymorphisms correspond to mutations in the coding sequence of the APOE gene resulting in amino acid substitutions (Arg and Cys) at positions 112 and 158 of the protein. 

Phrase: "These polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "correspond to mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the coding sequence"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0079941:Coding Sequence [Gene or Genome]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0009219:Coding [Occupational Activity]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "resulting in amino acid substitutions"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   862   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C0332294:Resulting in [Functional Concept]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726   C1555721:Substitution [Idea or Concept]
   726   C1706204:Substitution [Activity]
   726 E C2825142:Result [Finding]

Phrase: "(Arg"

Phrase: "and"

Phrase: "Cys) at positions 112"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "158 of the protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.11: This gene is located on chromosome 19 at position q13.2. 

Phrase: "This gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "located on chromosome 19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008661:Chromosome 19 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "at position q13.2."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0733755:Position [Spatial Concept]
   827   C1549864:Q13 [Intellectual Product]
   755 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.12: The implication of chromosome 19 in Alzheimer's disease (AD) was suspected on at least three occasions (1-3) before the report of an association between late-onset AD and the APOE [epsis]4 allele (4). 

Phrase: "The implication of chromosome 19"

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "was"

Phrase: "suspected on"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332147:Suspected [Qualitative Concept]
   833   C0750491:Suspected [Idea or Concept]
   799 E C1571873:Suspect [Idea or Concept]

Phrase: "at least three occasions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   743   C0521114:Occasional [Temporal Concept]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "before the report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "of an association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "between late-onset AD"

Phrase: "and"

Phrase: "the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.13: Numerous studies confirmed this finding and extended this observation to early-onset AD (5-7). 

Phrase: "Numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "and"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "this observation to early-onset AD (5-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0302523:Observation [Research Activity]
   744   C0700325:observation [Health Care Activity]
   744   C1964257:Observation [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.14: It is now established that carrying an [epsis]4 allele increases the risk of AD in an allele dose dependent manner and shifts the age of onset of the disease to earlier ages (8). 

Phrase: "It"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "an [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in an allele dose dependent manner"

Phrase: "and"

Phrase: "shifts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the age of onset of the disease to earlier ages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C1835401:Early age of onset [Finding]
   782   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   739   C0001779:Age [Organism Attribute]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.15: Conversely, bearing an [epsis]2 allele confers a protection against the disease (5,9,10). 

Phrase: "Conversely,"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "an [epsis"

Phrase: "]2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "confers"

Phrase: "a protection against the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.16: Thus, the APOE genotype appears as an important biological marker for AD susceptibility accounting for between 45 and 60% of AD genetic variability. 

Phrase: "Thus,"

Phrase: "the APOE genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017431:Genotype [Organism Attribute]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "appears as an important biological marker"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0005516:Marker, Biological [Clinical Attribute]
           Marker
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205460:biological [Qualitative Concept]
   753   C0700364:APPEAR [Qualitative Concept]

Phrase: "for AD susceptibility accounting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0000938:Accounting [Occupational Activity]

Phrase: "for"

Phrase: "between 45"

Phrase: "and"

Phrase: "60% of AD genetic variability."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C2827666:Variability [Conceptual Entity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.17: Several biological mechanisms have been proposed to underlie this association. 

Phrase: "Several biological mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underlie"

Phrase: "this association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]
Processing 00000000.tx.18: The E4 isoform would facilitate or not limit the amyloid substance deposition (11,12). 

Phrase: "The E4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "would"

Phrase: "facilitate"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the amyloid substance deposition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0011560:Amyloid deposition [Pathologic Function]
   913   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]
   734   C0002716:Amyloid Substance [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0002723:amyloid substance [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.19: This isoform may not protect against oxidative stress, in contrast to the E2 isoform (13). 

Phrase: "This isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "protect against oxidative stress,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "in contrast to the E2 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.20: It has also been suggested that the E2 and E3 isoforms would prevent the aggregation of Tau protein by limiting abnormal phosphorylation leading to the constitution of paired helical filament, while the E4 isoform would not (14). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "E3 isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "would"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the aggregation of Tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "by limiting abnormal phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "leading to the constitution of paired helical filament,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   800   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   744   C0009807:Constitution [Regulation or Law]
   744   C0010851:Filament [Cell Component]
   744   C0332152:Leading [Temporal Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1709450:Paired [Qualitative Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "while"

Phrase: "the E4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "would"

Phrase: "not (14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.21: However, none of these hypotheses fully explained why as many as 50% of homozygous subjects who survive until 80 years, do not develop AD. 

Phrase: "However,"

Phrase: "none of these hypotheses fully"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726   C1512571:Hypothesis [Idea or Concept]

Phrase: "explained"

Phrase: "why"

Phrase: "as"

Phrase: "many as 50% of homozygous subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0019904:Homozygous [Organism Attribute]
   753   C0439064:Many [Quantitative Concept]
   753   C0747726:many [Conceptual Entity]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "survive until 80 years,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0310255:SURVIVE [Pharmacologic Substance]
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "AD."
Processing 00000000.tx.22: This observation suggests that other factors should influence the APOE associated risk. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "should"

Phrase: "influence"

Phrase: "the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.23: Indeed, other genetic and environmental factors such as family history, gender, smoking, oestrogen, cholesterol level or other polymorphisms located in APOE receptor genes for instance (15-20), may modify the APOE associated risk. 

Phrase: "Indeed,"

Phrase: "other genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "environmental factors such as family history,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1516998:Environmental Factors [Functional Concept]
   773 E C0686732:Environmental Factor [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "smoking"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]
   966 E C0037366:Smoke [Environmental Effect of Humans,Hazardous or Poisonous Substance]
   966 E C0439994:Smoke [Hazardous or Poisonous Substance]

Phrase: ","

Phrase: "oestrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "cholesterol level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0201950:cholesterol level [Laboratory Procedure]
  1000   C0428466:Cholesterol level [Laboratory or Test Result]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "other polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "located in APOE receptor genes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C1412481:Apolipoprotein E gene [Gene or Genome]
   804   C0051300:Receptor, Apolipoprotein E [Amino Acid, Peptide, or Protein,Receptor]
   804   C1416912:APOLIPOPROTEIN E RECEPTOR [Gene or Genome]
           APOLIPOPROTEIN RECEPTOR
   804   C2987172:Apolipoprotein E Receptor [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1335671:Receptor Gene [Gene or Genome]
   774   C1445865:Apolipoprotein gene [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Gene [Gene or Genome]
           Genes
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "(15-20"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.24: However, recent reports suggest that additional genetic factors within the APOE locus itself may also modulate this risk. 

Phrase: "However,"

Phrase: "recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that additional genetic factors within the APOE locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0678933:Genetic Locus [Gene or Genome]
   739   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   739   C0314603:Genetic [Functional Concept]
   706   C1521761:Factor [Functional Concept]
   706   C2827422:Factor [Conceptual Entity]

Phrase: "itself"

Phrase: "may"

Phrase: "also"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "this risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.25: Firstly, a genetic study of markers in the vicinity of the APOE locus demonstrated that a combination of three polymorphisms increases the estimation of the APOE associated risk of AD compared with APOE polymorphism alone (5). 

Phrase: "Firstly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279901:Firstly [Qualitative Concept]

Phrase: "a genetic study of markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2827447:Genetic Study [Research Activity]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "in the vicinity"

Phrase: "of the APOE locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1708726:Gene Locus [Gene or Genome]
           Locus
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a combination of three polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the estimation of the APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0680844:estimation [Mental Process]
   748   C0681916:Estimation [Quantitative Concept]
   748   C0750572:Estimation [Quantitative Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "risk of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "compared with APOE polymorphism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1412481:Apolipoprotein E gene [Gene or Genome]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0678951:gene polymorphism [Genetic Function]
   783   C1445865:Apolipoprotein gene [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]
   753   C0032529:Polymorphism [Genetic Function]
   753   C1707455:Compared [Activity]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.26: Secondly, a distortion of the allelic expression of the APOE gene is observed in the brain of affected patients; 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "a distortion of the allelic expression of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0332482:Distortion [Anatomical Abnormality]
   736   C2919017:Distortion [Qualitative Concept]

Phrase: "is"

Phrase: "observed in the brain of affected patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0522476:affected patients [Qualitative Concept]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0392760:Affected [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1314939:Affected [Functional Concept]
   748   C1441672:Observed [Functional Concept]

Phrase: ";"
Processing 00000000.tx.27: indeed, the relative expression of the [epsis]4 allele is increased 1.5-fold in the [epsis]3/[epsis]4 bearer AD patients, compared with [epsis]3/[epsis]4 bearer controls (21). 

Phrase: "indeed,"

Phrase: "the relative expression of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "1.5-fold in the [epsis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 bearer AD patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 bearer controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.28: Together, these data suggest the potential existence of one or more additional genetic susceptibility factors in the APOE sequence, modifying the risk associated with the APOE [epsis]4 allele in the occurrence of AD. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the potential existence of one"

Phrase: "or"

Phrase: "more additional genetic susceptibility factors in the APOE sequence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1521761:Factor [Functional Concept]
   704   C2827422:Factor [Conceptual Entity]

Phrase: "modifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392747:MODIFY [Functional Concept]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the APOE"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1412481:Apolipoprotein E gene [Gene or Genome]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C1445865:Apolipoprotein gene [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[epsis"

Phrase: "]4 allele in the occurrence of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.29: Detailed sequence analyses and a study of the APOE locus are needed to characterise such additional genetic factors. 

Phrase: "Detailed sequence analyses"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "a study of the APOE locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterise"

Phrase: "such additional genetic factors."
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]
Processing 00000000.tx.30: For instance, Mui et al. reported a polymorphism (1E1) in the first intron of the APOE gene in strong linkage disequilibrium with the APOE [epsis]4 allele (22). 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "Mui et al."

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(1E1"

Phrase: ")"

Phrase: "in the first intron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "in strong linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.31: To go further in this hunt for other polymorphism(s), we sequenced the 375 bp upstream of the APOE TATA box and detected a new polymorphism whose impact on AD risk, together with the APOE [epsis]4 allele was investigated in a large case-control study. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "further in this hunt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]

Phrase: "for other polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "the 375 bp upstream of the APOE TATA box"

Phrase: "and"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a new polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "whose impact on AD risk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "together with the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "investigated in a large case-control study."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0007328:Case-Control Study [Research Activity]
   778   C0872128:case control [Health Care Activity]
   774   C0085973:Case Study [Intellectual Product]
   748   C0243148:control [Qualitative Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0868928:Case [Functional Concept]
   748   C1292732:investigated [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2603343:Study [Research Activity]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.32: RESULTS Sequencing the 375 bp upstream to the TATA box of APOE, we found a (G[rarr]T) polymorphism at position -186 of the TATA box, located in a potential consensus binding sequence of the Th1/E47 heterodimer transcriptional factor (Fig. 1) (23). 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "Sequencing"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162326:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]

Phrase: "the 375 bp"

Phrase: "upstream to the TATA box of APOE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522505:Upstream [Spatial Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a (G[rarr"

Phrase: "]T) polymorphism at position -186 of the TATA box,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "located in a potential consensus binding sequence"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0079160:Consensus Sequence [Nucleotide Sequence]
   774   C2986841:Binding Potential [Phenomenon or Process]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0243122:binding [Functional Concept]
   748   C0376298:Consensus [Social Behavior]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1519249:Sequence [Functional Concept]
   748   C3245505:Potential [Qualitative Concept]

Phrase: "of the Th1/E47 heterodimer transcriptional factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcriptional [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.33: Because of this location, we named it Th1/E47cs polymorphism (for Th1/E47 consensus sequence polymorphism). 

Phrase: "Because of this location,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450429:Location [Spatial Concept]
  1000   C1515974:Location [Body Location or Region]

Phrase: "we"

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "it Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "for Th1/E47 consensus sequence polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.34: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.35: (a) Autoradiograph of a sequencing gel from part of the APOE promoter in an heterozygous Th1/E47cs individual showing the G[rarr]T base-pair change. 

Phrase: "(a) Autoradiograph of a sequencing gel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986957:Autoradiograph [Manufactured Object]

Phrase: "from part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the APOE promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "in an heterozygous Th1/E47cs individual showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1547282:Show [Intellectual Product]

Phrase: "the G[rarr"

Phrase: "]T base-pair change."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0392747:Change [Functional Concept]
   812   C0443172:change [Quantitative Concept]
   812   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.36: (b) Comparison of the APOE promoter sequence including the Th1/E47cs polymorphism and the consensus sequence of the predicted binding site of the Th1/E47cs heterodimer (21). 

Phrase: "(b) Comparison of the APOE promoter sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the consensus sequence of the predicted binding site of the Th1/E47cs heterodimer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C0079160:Consensus Sequence [Nucleotide Sequence]
   735   C0004793:Sequence [Nucleotide Sequence]
   735   C0162326:Sequence [Nucleotide Sequence]
   735   C0162327:Sequence [Nucleotide Sequence]
   735   C0376298:Consensus [Social Behavior]
   735   C1519249:Sequence [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.37: The predicted positions of Th1 and E47 binding site are indicated at the top and are based on the known half-site specificity of E47 and that predicted for Th1. 

Phrase: "The predicted positions of Th1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "E47 binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "indicated at the top"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   770   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "based on the known half-site specificity of E47"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   762   C2945843:Site of [Qualitative Concept]
   742   C0037791:Specificity [Quantitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C0205309:Known [Qualitative Concept]
   742   C1336596:E47 [Gene or Genome]
   742   C1511884:Specificity [Quantitative Concept]
   742   C1515974:Site [Body Location or Region]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C2825164:Site [Spatial Concept]
   742   C2825407:Half [Quantitative Concept]
   729   C0449604:site specific [Spatial Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "that"

Phrase: "predicted for Th1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0681842:Predicted [Idea or Concept]
   790   C1423842:TH1 [Gene or Genome]
   790   C1882327:%{Predicted} [Quantitative Concept]
   790   C3540579:TH1 [Gene or Genome]
Processing 00000000.tx.38: The G[rarr]T mutation (boxed) is located in the half-site specificity of E47. 

Phrase: "The G[rarr"

Phrase: "]T mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "is"

Phrase: "located in the half-site specificity of E47."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C2945843:Site of [Qualitative Concept]
   744   C0037791:Specificity [Quantitative Concept]
   744   C0205145:Site [Spatial Concept]
   744   C1336596:E47 [Gene or Genome]
   744   C1511884:Specificity [Quantitative Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
   744   C2825407:Half [Quantitative Concept]
   735   C0449604:site specific [Spatial Concept]
Processing 00000000.tx.39: Nucleotide positions are numbered relative to the canonical E-box sequence. 

Phrase: "Nucleotide positions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "are"

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "relative to the canonical E-box sequence."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.40: We studied the association of the Th1/E47cs polymorphism with AD in a large case-control study (310 cases, age = 74.6  9.3 years; 293 controls, age = 73.5  10.9 years). 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the association of the Th1/E47cs polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with AD"

Phrase: "in a large case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0007328:Case-Control Study [Research Activity]
   875   C0085973:Case Study [Intellectual Product]
   861   C0872128:case control [Health Care Activity]
   812   C0243148:control [Qualitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0868928:Case [Functional Concept]
   812   C1550141:Control [Substance]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C2603343:Study [Research Activity]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(310 cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "age = 74.6  9.3 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   895   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: "; 293 controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "age = 73.5  10.9 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   895   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.41: We analysed the Th1/E47cs polymorphism together with the APOE, the 1E1 and the D19S178 repeat polymorphisms. 

Phrase: "We"

Phrase: "analysed"

Phrase: "the Th1/E47cs polymorphism together with the APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "the 1E1"

Phrase: "and"

Phrase: "the D19S178 repeat polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.42: The distributions of these polymorphisms are presented in Table 1. 

Phrase: "The distributions of these polymorphisms"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0037775:Distributions [Spatial Concept]
   726 E C0520511:distribution [Idea or Concept]
   726 E C1704711:Distribution [Functional Concept]

Phrase: "are"

Phrase: "presented in Table 1."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.43: No deviation from the Hardy-Weinberg equilibrium were observed for any of these polymorphisms. 

Phrase: "No deviation from the Hardy-Weinberg equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0012727:Deviation [Spatial Concept]
   748   C0205419:Deviation [Qualitative Concept]
   748   C1705236:Deviation [Finding]

Phrase: "were"

Phrase: "observed for any of these polymorphisms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0032529:polymorphisms [Genetic Function]
   753   C1441672:Observed [Functional Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.44: As expected, the [epsis]4 allele was strongly associated with AD (OR = 4.67, 95% IC [3.28-6.67]), while the [epsis]2 allele exhibited a protective effect (OR = 0.27, 95% CI [0.14-0.52]). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "strongly"

Phrase: "associated with AD (OR = 4.67,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "95% IC [3.28-6.67"

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the [epsis"

Phrase: "]2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a protective effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(OR = 0.27,"

Phrase: "95% CI [0.14-0.52"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.45: In the control population, the Th1/E47cs G allele was the common one (0.531), in contrast to the AD population (0.468). 

Phrase: "In the control population,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the Th1/E47cs G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "the common one (0.531"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205214:Common [Quantitative Concept]
   812   C0205447:One [Quantitative Concept]
   812   C1522138:Common [Functional Concept]
   812   C3245511:common [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "in contrast to the AD population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(0.468"

Phrase: ")."
Processing 00000000.tx.46: The allelic and genotypic distributions were significantly different in the AD cases when compared with the control cases (P = 0.03 and P = 0.007, respectively). 

Phrase: "The allelic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotypic distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "significantly different in the AD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "when"

Phrase: "compared with the control cases"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   781   C0872128:case control [Health Care Activity]
   760   C0243148:control [Qualitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "(P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P = 0.007,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.47: The Th1/E47cs T allele was associated with an increased risk of developing AD (OR = 1.29, CI 95% [1.02-1.63]) and the OR was 1.79 (CI 95% [1.21-2.65], P = 0.002) for individuals bearing at least one T allele. 

Phrase: "The Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "of developing AD (OR = 1.29,"

Phrase: "CI 95%"

Phrase: "[1.02-1.63"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "]"

Phrase: ")"

Phrase: "and"

Phrase: "the"

Phrase: "OR"

Phrase: "was"

Phrase: "1.79"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(CI 95%"

Phrase: "[1.21-2.65"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0580272:1/2 [Intellectual Product]
   875   C1519043:1-2 [Research Activity]
   812   C0450385:65 [Intellectual Product]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "],"

Phrase: "P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing at least one T allele."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0002085:Allele [Gene or Genome]
   753   C0205447:One [Quantitative Concept]
   753   C1704689:Bearing [Medical Device]
   719 E C0004897:Bear [Mammal]
Processing 00000000.tx.48: For the 1E1 polymorphism, the allelic and genotypic distributions, similar to the ones reported by Mui et al. 

Phrase: "For the 1E1 polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "the allelic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotypic distributions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]

Phrase: "similar to the ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "reported by Mui et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.49: (20), were significantly different between the AD and control populations (P = 0.002 and P = 0.0005, respectively). 

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "significantly different between the AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "control populations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P = 0.0005,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.50: The 1E1 C allele was associated with a decreased risk of developing AD (OR = 0.56, CI 95% [0.40-0.78], P = 0.0003). 

Phrase: "The 1E1 C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "associated with a decreased risk"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "of developing AD (OR = 0.56,"

Phrase: "CI 95%"

Phrase: "[0.40-0.78"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: "],"

Phrase: "P = 0.0003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.51: No difference in the allelic or genotypic distributions of the D19S178 repeat alleles was observed (P = 0.90 and P = 0.95, respectively). 

Phrase: "No difference in the allelic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "genotypic distributions of the D19S178 repeat alleles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0037775:Distributions [Spatial Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(P = 0.90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439083:>90 [Quantitative Concept]
   827   C0439087:<90 [Quantitative Concept]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P = 0.95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.52: We calculated pairwise linkage disequilibriums between D19S178, Th1/E47cs, 1E1 and APOE polymorphisms (Table 2). 

Phrase: "We"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "pairwise linkage disequilibriums between D19S178,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0023746:Linkage Disequilibriums [Quantitative Concept]
   726   C0281825:Disequilibrium [Finding]
   726   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "Th1/E47cs,"

Phrase: "1E1"

Phrase: "and"

Phrase: "APOE polymorphisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0678951:gene polymorphisms [Genetic Function]
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: As expected significant linkage disequilibriums existed between Th1/E47cs, 1E1 and APOE polymorphisms. 

Phrase: "As expected significant linkage disequilibriums"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023746:Linkage Disequilibriums [Quantitative Concept]
   779   C0281825:Disequilibrium [Finding]
   779   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "existed between Th1/E47cs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1423842:TH1 [Gene or Genome]
   770   C3540579:TH1 [Gene or Genome]
   737   C2987476:Exist [Conceptual Entity]

Phrase: "1E1"

Phrase: "and"

Phrase: "APOE polymorphisms."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0678951:gene polymorphisms [Genetic Function]
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]
Processing 00000000.tx.54: D19S178 was independent of the other polymorphisms, although a weak linkage disequilibrium existed with APOE in the control population. 

Phrase: "D19S178"

Phrase: "was independent of the"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332291:Independent of [Functional Concept]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0085862:Independent [Idea or Concept]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1299583:Independent [Finding]
   770   C1421478:WAS [Gene or Genome]

Phrase: "other polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "although"

Phrase: "a weak linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "existed with APOE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1412481:Apolipoprotein E gene [Gene or Genome]
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1445865:Apolipoprotein gene [Gene or Genome]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   726   C2987476:Exist [Conceptual Entity]

Phrase: "in the control population."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.55: We estimated the haplotypes generated by these four polymorphisms using the myriad haplotype algorithm. 

Phrase: "We"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "the haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "generated by these four polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0205450:Four [Quantitative Concept]
   760   C3146294:Generated [Activity]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the myriad haplotype algorithm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002045:algorithm [Intellectual Product]
   827   C1553907:algorithm [Laboratory Procedure]
Processing 00000000.tx.56: Among the 16 theoretical haplotypes, 15 were observed (Table 3a). 

Phrase: "Among the 16 theoretical haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "15"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Table 3a"

Phrase: ")."
Processing 00000000.tx.57: All haplotypes were observed in AD cases, while three (nos 2, 5 and 7) were not represented in controls. 

Phrase: "All haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "observed in AD cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "while"

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "(nos 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represented in controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882932:Represent [Activity]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.58: The difference in the distribution of the estimated haplotype frequencies between cases and controls was tested with a likelihood ratio test with 13 degrees of freedom ([chi]2 = 696). 

Phrase: "The difference in the distribution of the estimated haplotype frequencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "between cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "tested with a likelihood ratio test"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   767   C0683443:test test [Diagnostic Procedure]
   753   C0033204:Likelihood [Quantitative Concept]
   753   C0392366:tested [Intellectual Product]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]

Phrase: "with 13 degrees"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "of freedom"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0016694:Freedom [Idea or Concept]
   928 E C0332296:free [Functional Concept]
   928 E C1880497:Free [Qualitative Concept]
   928 E C1996904:Free [Qualitative Concept]

Phrase: "("

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "= 696"

Phrase: ")."
Processing 00000000.tx.59: To take into account the strong association of the APOE [epsis]4 allele with AD, we compared the estimated haplotype distributions in the [epsis]3/[epsis]3 and in the [epsis]3/[epsis]4 AD and control subgroups (Table 3b and c). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "take into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the strong association of the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "[epsis"

Phrase: "]4 allele with AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002085:Allele [Gene or Genome]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the estimated haplotype distributions in the [epsis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0037775:Distributions [Spatial Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 AD"

Phrase: "and"

Phrase: "control subgroups"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1079230:subgroups [Virus]
   827 E C1515021:Subgroup [Classification]

Phrase: "(Table 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "and"

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.60: In each subgroup ([epsis]3/[epsis]3 and [epsis]3/[epsis]4 genotype bearers, respectively), the estimated haplotype distributions were significantly different between AD and control subjects (likelihood test [chi]2 = 374, df = 8 and [chi]2 = 160, df = 6, respectively), suggesting potential independent effect of the other polymorphisms. 

Phrase: "In each subgroup"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1079230:subgroup [Virus]
  1000   C1515021:Subgroup [Classification]

Phrase: "("

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 genotype bearers,"

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "the estimated haplotype distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037775:Distributions [Spatial Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "significantly different between AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(likelihood test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "= 374,"

Phrase: "df = 8"

Phrase: "and ["

Phrase: "chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "= 160,"

Phrase: "df = 6,"

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "potential independent effect of the"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0332291:Independent of [Functional Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1299583:Independent [Finding]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "other polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.61: Table 1. 

Phrase: "Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.62: Distribution and combination of the different polymorphism alleles in the controls and AD cases   Allele frequency Genotype frequency APOEa n [epsis]2 [epsis]3 [epsis]4 [epsis]2/[epsis]2 [epsis]2/[epsis]3 [epsis]2/[epsis]4 [epsis]3/[epsis]3 [epsis]3/[epsis]4 [epsis]4/[epsis]4 Control cases 308 0.081 0.805 0.114 0.003 0.133 0.230 0.649 0.179 0.130 AD cases 292 0.034 0.639 0.327 - 0.034 0.034 0.425 0.393 0.113 Th1/E47cs n Gb T  GGc GT TT    Control cases 310 0.531 0.469  0.320 0.422 0.258    AD cases 279 0.468 0.532  0.208 0.520 0.272    1E1 n Gd C  GGe GC CC    Control cases 307 0.615 0.385  0.388 0.456 0.156    AD cases 293 0.711 0.289  0.533 0.382 0.085    D19S178f n L S  LL LS SS    Control cases 272 0.498 0.502  0.246 0.504 0.250    AD cases 276 0.507 0.493  0.257 0.500 0.243     n [epsis]2/[epsis]3g [epsis]3/[epsis]3  [epsis]3/[epsis]4 [epsis]4/[epsis]4 [epsis]2/[epsis]4    APOE and 1E1 polymorphism combination AD cases CC 22 1 20 - 1 -     GC 100 4 50 46 - -     GG 139 4 44 56 27 8     Total 261 9 114 102 28 8     Control cases CC 41 0 41 0 - -     GC 112 12 76 24 - -     GG 100 25 50 15 3 7     Total 253 37 167 39 3 7     APOE and Th1/E47cs polymorphism combination AD cases GG 55 4 36 13 1 1     GT 134 5 54 60 8 7     TT 78 - 24 29 19 -     Total 261 9 114 102 28 8     Control cases GG 85 25 52 5 - 3     GT 108 11 76 16 1 4     TT 60 1 39 18 2 -     Total 253 36 167 39 3 7     aP < 0.001; 

Phrase: "Distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "combination of the different polymorphism alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "in the controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "AD cases   Allele frequency Genotype frequency APOEa n [epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4/"

Phrase: "[epsis"

Phrase: "]4 Control cases 308 0.081 0.805 0.114 0.003 0.133 0.230 0.649 0.179 0.130 AD cases 292 0.034 0.639 0.327 - 0.034 0.034 0.425 0.393 0.113 Th1/E47cs n Gb T  GGc GT TT    Control cases 310 0.531 0.469  0.320 0.422 0.258    AD cases 279 0.468 0.532  0.208 0.520 0.272    1E1 n Gd C  GGe GC CC    Control cases 307 0.615 0.385  0.388 0.456 0.156    AD cases 293 0.711 0.289  0.533 0.382 0.085    D19S178f n L S  LL LS SS    Control cases 272 0.498 0.502  0.246 0.504 0.250    AD cases 276 0.507 0.493  0.257 0.500 0.243     n [epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3g"

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]4/"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "[epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]4    APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "1E1 polymorphism combination AD cases CC 22 1 20 - 1 -     GC 100 4 50 46"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   823   C0050714:AD 20 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   815   C0601416:GC-46 [Organic Chemical,Pharmacologic Substance]
   800   C1705070:CC-1 [Gene or Genome]
   785   C0032529:Polymorphism [Genetic Function]
   785   C0205195:Combination [Qualitative Concept]
   785   C0868928:Cases [Functional Concept]
   785   C1533148:Cases [Quantitative Concept]
   785   C1882417:Polymorphism [Qualitative Concept]
   785   C1947911:Combination [Physical Object]
   785   C3537453:GC [Gene or Genome]
   785   C3538933:CC [Cell Component]
   752 E C1706255:CASE [Medical Device]
   752 E C1706256:Case [Conceptual Entity]

Phrase: "- -"

Phrase: "GG 139 4 44 56 27 8     Total 261 9 114 102 28 8     Control cases CC 41 0 41 0"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   783   C0018370:GG [Geographic Area]
   783   C0243148:control [Qualitative Concept]
   783   C0439175:% total [Quantitative Concept]
   783   C0439810:Total [Qualitative Concept]
   783   C0868928:Cases [Functional Concept]
   783   C1533148:Cases [Quantitative Concept]
   783   C1550141:Control [Substance]
   783   C1882979:Control [Conceptual Entity]
   783   C2587213:Control [Functional Concept]
   783   C3274648:Control [Qualitative Concept]
   783   C3538933:CC [Cell Component]
   749 E C1706255:CASE [Medical Device]
   749 E C1706256:Case [Conceptual Entity]

Phrase: "- -"

Phrase: "GC 112 12 76 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3537453:GC [Gene or Genome]

Phrase: "- -"

Phrase: "GG 100 25 50 15 3 7     Total 253 37 167 39 3 7     APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1412481:Apolipoprotein E gene [Gene or Genome]
   798   C1445865:Apolipoprotein gene [Gene or Genome]
   784   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "Th1/E47cs polymorphism combination AD cases GG 55 4 36 13 1 1     GT 134 5 54 60 8 7     TT 78 - 24 29 19 -     Total 261 9 114 102 28 8     Control cases GG 85 25 52 5 - 3     GT 108 11 76 16 1 4     TT 60 1 39 18 2 -     Total 253 36 167 39 3 7     aP < 0.001"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
   867   C0379939:GG 167 [Organic Chemical,Pharmacologic Substance]
   848   C0379660:GT-2 [Amino Acid, Peptide, or Protein]
   846   C0617965:AD 11 [Organic Chemical,Pharmacologic Substance]
   814   C0648082:AD 19 [Organic Chemical,Pharmacologic Substance]
   810   C0872128:case control [Health Care Activity]
   809   C0616864:GT 28 [Organic Chemical,Pharmacologic Substance]
   807   C0090566:16-AP [Lipid]
   798   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   779   C0018370:GG [Geographic Area]
   779   C0032529:Polymorphism [Genetic Function]
   779   C0205195:Combination [Qualitative Concept]
   779   C0243148:control [Qualitative Concept]
   779   C0439175:% total [Quantitative Concept]
   779   C0439810:Total [Qualitative Concept]
   779   C0450382:55 [Intellectual Product]
   779   C0868928:Cases [Functional Concept]
   779   C1423842:TH1 [Gene or Genome]
   779   C1533148:Cases [Quantitative Concept]
   779   C1550141:Control [Substance]
   779   C1882417:Polymorphism [Qualitative Concept]
   779   C1882979:Control [Conceptual Entity]
   779   C1947911:Combination [Physical Object]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]
   779   C3540579:TH1 [Gene or Genome]
   746 E C1706255:CASE [Medical Device]
   746 E C1706256:Case [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.63: bP = 0.03, OR(T+/T-) = 1.29, CI 95% [1.02-1.63]; 

Phrase: "bP = 0.03,"

Phrase: "OR(T+/T-) = 1.29,"

Phrase: "CI 95%"

Phrase: "[1.02-1.63"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.64: cP = 0.007; 

Phrase: "cP = 0.007"

Phrase: ";"
Processing 00000000.tx.65: dP = 0.002, OR(G+/G-) = 1.44, CI 95% [1.14-1.84]; 

Phrase: "dP = 0.002,"

Phrase: "OR(G+/G-) = 1.44,"

Phrase: "CI 95%"

Phrase: "[1.14-1.84"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.66: eP = 0.0005; 

Phrase: "eP = 0.0005"

Phrase: ";"
Processing 00000000.tx.67: fNS; 

Phrase: "fNS"

Phrase: ";"
Processing 00000000.tx.68: gone individual was [epsis]2/[epsis]2 in control cases. 

Phrase: "gone individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "was ["

Phrase: "epsis"

Phrase: "]2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]2 in control cases."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   802   C0872128:case control [Health Care Activity]
   770   C0243148:control [Qualitative Concept]
   770   C0740116:+2 [Quantitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.69: Table 2. 

Phrase: "Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.70: Pairwise linkage disequilibrium in the 19q13.2 chromosomal region  D19S178 Th1/E47cs 1E1 APOE AD cases D19S178 - -1.0 -0.6 0.6 Th1/E47cs 7 - -8.4 -5.8 1E1 6 79 - -6.1 APOE 6 49 54 - Controls D19S178 - 0.5 0.1 1.2 Th1/E47cs 3 - 11.9 -1.9 1E1 1 86 - -3.7 APOE  32 42 - APOE polymorphism was analysed as a biallelic marker (i.e., allele 4 versus allele 2 or 3). 

Phrase: "Pairwise linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in the 19q13.2 chromosomal region  D19S178 Th1/E47cs 1E1 APOE AD cases D19S178"

Phrase: "- -"

Phrase: "1.0 -0.6 0.6 Th1/E47cs 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1423842:TH1 [Gene or Genome]
   791   C3540579:TH1 [Gene or Genome]

Phrase: "- -"

Phrase: "8.4 -5.8 1E1 6 79"

Phrase: "- -"

Phrase: "6.1 APOE 6 49 54 -"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C0442750:6/6 [Finding]
   835   C1412481:Apolipoprotein E gene [Gene or Genome]
   822   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0017337:Gene [Gene or Genome]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "D19S178 - 0.5 0.1 1.2 Th1/E47cs 3 - 11.9 -1.9 1E1 1 86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   784   C1423842:TH1 [Gene or Genome]
   784   C3540579:TH1 [Gene or Genome]

Phrase: "- -"

Phrase: "3.7 APOE  32 42 - APOE polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   850   C0678951:gene polymorphism [Genetic Function]
   788   C0032529:Polymorphism [Genetic Function]
   788   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "analysed as a biallelic marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "(i.e.,"

Phrase: "allele 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "versus"

Phrase: "allele 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "or"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.71: Above, the diagonal [Delta] standardised linkage disequilibrium coefficient. 

Phrase: "Above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "the diagonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443198:Diagonal [Spatial Concept]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "] standardised linkage disequilibrium coefficient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707429:*Coefficient [Quantitative Concept]
Processing 00000000.tx.72: Below, the diagonal D[prime] percentage of the linkage disequilibrium coefficient maximum possible value at the given allele frequencies. 

Phrase: "Below,"

Phrase: "the diagonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443198:Diagonal [Spatial Concept]

Phrase: "D["

Phrase: "prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "] percentage of the linkage disequilibrium coefficient maximum possible value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0439165:Percentage [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]

Phrase: "at the given allele frequencies."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0017270:Frequencies, Allele [Quantitative Concept]
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.73: Table 3. 

Phrase: "Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.74: Polymorphism haplotype estimations along the 19q.13.2 chromosomal region Haplotype Polymorphisms Estimated haplotype frequencies No. 

Phrase: "Polymorphism haplotype estimations along the 19q.13.2 chromosomal region Haplotype Polymorphisms"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   736   C0680844:estimations [Mental Process]
   703 E C0681916:Estimation [Quantitative Concept]
   703 E C0750572:Estimation [Quantitative Concept]

Phrase: "Estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "No."
Processing 00000000.tx.75: D19S178 Th1/E47cs 1E1 APOE AD cases Controls Expected controls (a) General population 1 S T G [epsis]4+ 0.130 0.032 0.029 2 S T C [epsis]4+ 0.004 0.000 0.019a 3 S G G [epsis]4+ 0.031 0.006 0.035a 4 L T G [epsis]4+ 0.100 0.043 0.027 5 L T C [epsis]4+ 0.005 0.000 0.018a 6 L G G [epsis]4+ 0.044 0.022 0.033 7 L G C [epsis]4+ 0.003 0.000 0.021a 8 S T G [epsis]4- 0.018 0.009 0.114a 9 S T C [epsis]4- 0.127 0.183 0.072a 10 S G G [epsis]4- 0.184 0.267 0.142a 11 S G C [epsis]4- 0.000 0.011 0.087a 12 L T G [epsis]4- 0.020 0.014 0.113a 13 L T C [epsis]4- 0.128 0.170 0.070a 14 L G G [epsis]4- 0.195 0.224 0.136a 15 L G C [epsis]4- 0.011 0.019 0.084a Number of chromosomes 522 506  (b) Population genotyped [epsis]3/[epsis]3 1 S T G  0.035 0.014 0.129a 2 S T C  0.192 0.239 0.116a 3 S G G  0.259 0.268 0.151a 4 S G C  0.009 0.013 0.136a 5 L T G  0.027 0.010 0.113a 6 L T C  0.193 0.198 0.103a 7 L G G  0.285 0.234 0.133a 8 L G C  0.000 0.024 0.119a Number of chromosomes 228 334  (c) Population genotyped [epsis]3/[epsis]4 1 S T G  0.184 0.154 0.207 2 S T C  0.102 0.148 0.092 3 S G G  0.169 0.145 0.103 4 S G C  0.000 0.000 0.046 5 L T G  0.179 0.204 0.254 6 L T C  0.113 0.158 0.127 7 L G G  0.237 0.188 0.113 8 L G C  0.015 0.000 0.056 Number of chromosomes 204 78  aP < 0.01. 

Phrase: "D19S178 Th1/E47cs 1E1 APOE AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   791   C0868928:Cases [Functional Concept]
   791   C1533148:Cases [Quantitative Concept]
   758 E C1706255:CASE [Medical Device]
   758 E C1706256:Case [Conceptual Entity]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Expected controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(a) General population 1 S T G [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C0718146:a s t [Antibiotic,Organic Chemical]

Phrase: "]4+ 0.130 0.032 0.029 2 S T C [epsis"

Phrase: "]4+ 0.004 0.000 0.019a 3 S G G [epsis"

Phrase: "]4+ 0.031 0.006 0.035a 4 L T G [epsis"

Phrase: "]4+ 0.100 0.043 0.027 5 L T C [epsis"

Phrase: "]4+ 0.005 0.000 0.018a 6 L G G [epsis"

Phrase: "]4+ 0.044 0.022 0.033 7 L G C [epsis"

Phrase: "]4+ 0.003 0.000 0.021a 8 S T G [epsis"

Phrase: "]4- 0.018 0.009 0.114a 9 S T C [epsis"

Phrase: "]4- 0.127 0.183 0.072a 10 S G G [epsis"

Phrase: "]4- 0.184 0.267 0.142a 11 S G C [epsis"

Phrase: "]4- 0.000 0.011 0.087a 12 L T G [epsis"

Phrase: "]4- 0.020 0.014 0.113a 13 L T C [epsis"

Phrase: "]4- 0.128 0.170 0.070a 14 L G G [epsis"

Phrase: "]4- 0.195 0.224 0.136a 15 L G C [epsis"

Phrase: "]4- 0.011 0.019 0.084a Number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0237753:*Number [Quantitative Concept]
   793   C0449788:Number [Quantitative Concept]

Phrase: "of chromosomes 522 506"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "(b) Population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3 1 S T G  0.035 0.014 0.129a 2 S T C  0.192 0.239 0.116a 3 S G G  0.259 0.268 0.151a 4 S G C  0.009 0.013 0.136a 5 L T G  0.027 0.010 0.113a 6 L T C  0.193 0.198 0.103a 7 L G G  0.285 0.234 0.133a 8 L G C  0.000 0.024 0.119a Number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0237753:*Number [Quantitative Concept]
   779   C0449788:Number [Quantitative Concept]

Phrase: "of chromosomes 228 334"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "(c) Population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 1 S T G  0.184 0.154 0.207 2 S T C  0.102 0.148 0.092 3 S G G  0.169 0.145 0.103 4 S G C  0.000 0.000 0.046 5 L T G  0.179 0.204 0.254 6 L T C  0.113 0.158 0.127 7 L G G  0.237 0.188 0.113 8 L G C  0.015 0.000 0.056 Number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0237753:*Number [Quantitative Concept]
   779   C0449788:Number [Quantitative Concept]

Phrase: "of chromosomes 204 78  aP < 0.01."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.76: In the whole population (AD = 261, Controls = 253), we estimated the OR for developing AD for subjects with at least one allele in the genotype for each polymorphism separately (Table 4). 

Phrase: "In the whole population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(AD = 261,"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "= 253"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "the"

Phrase: "OR for developing AD"

Phrase: "for subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with"

Phrase: "at least one allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "in the genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "for each polymorphism separately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: As expected a significant effect was observed for all of them except for D19S178. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "a significant effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed for all of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441672:Observed [Functional Concept]

Phrase: "except for D19S178."
Processing 00000000.tx.78: To determine if the effect of the Th1/E47cs and 1E1 polymorphisms were not due to the linkage disequilibrium existing with the APOE polymorphism, we performed a multivariate logistic regression taking into account age, gender, and the four polymorphisms in the same model. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the effect of the Th1/E47cs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "1E1 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "not due to the linkage disequilibrium existing"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0023746:Linkage Disequilibrium [Quantitative Concept]
   778   C0678226:Due to [Functional Concept]
           due
   748   C0023745:linkage [Molecular Function]
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]
   748   C1518422:Not [Functional Concept]
   748   C3146286:Due [Idea or Concept]
   714   C2987476:Exist [Conceptual Entity]

Phrase: "with the APOE polymorphism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0678951:gene polymorphism [Genetic Function]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a multivariate logistic regression taking into account age,"

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "the four polymorphisms in the same model."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.79: The effects of Th1/E47cs and 1E1 polymorphisms persisted and even increased, reinforcing the hypothesis of several genetic susceptibility factors within the APOE locus. 

Phrase: "The effects of Th1/E47cs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "1E1 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "persisted"

Phrase: "and"

Phrase: "even"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "reinforcing"

Phrase: "the hypothesis of several genetic susceptibility factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512571:Hypothesis [Idea or Concept]

Phrase: "within the APOE locus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1708726:Gene Locus [Gene or Genome]
           Locus
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]
Processing 00000000.tx.80: Table 4. 

Phrase: "Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.81: Adjusted odds ratio estimated with multiple logistic regression OR 95% CI D19S178 >SS + LS/LL Th1/E47cs TT + GT/GG 1E1 CC + GC/GG APOE with [epsis]4/without [epsis]4 Non adjusted 0.94 [0.63-1.41] P = 0.76< 1.79 [1.21-2.65] P = 0.002 0.56 [0.40-0.78] P = 0.0003 4.32 [2.98-6.28] P < 0.0001 Adjusted for 0.82 [0.46-1.46] 1.90 [1.28-2.83] 0.58 [0.41-0.82] 4.66 [3.14-6.93] age and gender P = 0.50 P = 0.002 P = 0.002 P < 0.0001 Adjusted for gender, age 0.87 [0.38-2.00] 2.51 [1.38-4.56] 0.43 [0.25-0.74] 3.22 [2.06-5.02] and other polymorphisms P = 0.75 P = 0.001 P = 0.002 P < 0.0001 If we assume that the level of expression of the APOE alleles is increased due to cis mutations in the promoter region, this hypothesis has three major implications: (i) the promoter mutation may modulate the expression of the APOE alleles leading to an increased deleterious risk for [epsis]4 and to an increased protective effect for [epsis]2; 

Phrase: "Adjusted odds ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456081:Adjusted [Functional Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "estimated with multiple logistic regression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0206031:Logistic Regression [Research Activity]
   797   C0681923:multiple regression [Qualitative Concept]
   760   C0242415:logistic [Occupational Activity]
   760   C0439064:Multiple [Quantitative Concept]
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]
   760   C0750572:Estimated [Quantitative Concept]

Phrase: "OR"

Phrase: "95% CI D19S178"

Phrase: ">SS + LS/LL Th1/E47cs TT + GT/GG 1E1 CC + GC/GG APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   815   C1367452:GC gene [Gene or Genome]
   804   C1412481:Apolipoprotein E gene [Gene or Genome]
   800   C1445865:Apolipoprotein gene [Gene or Genome]
   785   C0017337:Gene [Gene or Genome]

Phrase: "with"

Phrase: "[epsis"

Phrase: "]4/"

Phrase: "without"

Phrase: "[epsis"

Phrase: "]4 Non adjusted 0.94"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456081:Adjusted [Functional Concept]
   804   C1518422:Non [Functional Concept]

Phrase: "[0.63-1.41"

Phrase: "] P = 0.76"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "< 1.79"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[1.21-2.65"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0580272:1/2 [Intellectual Product]
   875   C1519043:1-2 [Research Activity]
   812   C0450385:65 [Intellectual Product]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "] P = 0.002 0.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C2603361:P' [Clinical Attribute]

Phrase: "[0.40-0.78"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: "] P = 0.0003 4.32"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0069881:P-32 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   897   C0851287:P-32 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C2603361:P' [Clinical Attribute]

Phrase: "[2.98-6.28"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "] P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Adjusted for 0.82"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456081:Adjusted [Functional Concept]

Phrase: "[0.46-1.46"

Phrase: "] 1.90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[1.28-2.83"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0580272:1/2 [Intellectual Product]
   875   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "] 0.58"

Phrase: "[0.41-0.82"

Phrase: "] 4.66"

Phrase: "[3.14-6.93"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0442759:3 6 [Finding]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "] age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "gender P = 0.50 P = 0.002 P = 0.002 P < 0.0001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "Adjusted for gender,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0079399:Gender [Organism Attribute]
   790   C0456081:Adjusted [Functional Concept]
   790   C0804628:Gender [Clinical Attribute]
   790   C1522384:Gender [Organism Attribute]

Phrase: "age 0.87"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001779:Age [Organism Attribute]

Phrase: "[0.38-2.00"

Phrase: "] 2.51"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[1.38-4.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "] 0.43"

Phrase: "[0.25-0.74"

Phrase: "] 3.22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "[2.06-5.02"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0450346:2 5 [Quantitative Concept]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "]"

Phrase: "and"

Phrase: "other polymorphisms P = 0.75 P = 0.001 P = 0.002 P < 0.0001"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   786   C0032529:polymorphisms [Genetic Function]
   753 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "If"

Phrase: "we"

Phrase: "assume"

Phrase: "that"

Phrase: "the level of expression of the APOE alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C3244092:expression level [Idea or Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "increased due to cis mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0026882:Mutations [Genetic Function]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1504308:Cis [Eukaryote]
   760   C3146286:Due [Idea or Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the promoter region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "has"

Phrase: "three major implications: (i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205164:Major [Qualitative Concept]
   827   C0205449:Three [Quantitative Concept]

Phrase: "the promoter mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the expression of the APOE alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leading to an increased deleterious risk"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0861064:increased lead [Finding]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and to an increased protective effect"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0595938:EFFECT INCREASED [Pathologic Function]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "for"

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.82: (ii) given that what determines the risk is the importance of the relative level of expression of both alleles of the APOE, this promoter mutation will have a differential effect in APOE heterozygous and homozygous genotypes; 

Phrase: "(ii"

Phrase: ")"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "what"

Phrase: "determines"

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "the importance of the relative level of expression of both alleles"

Phrase: "of the APOE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "this promoter mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "will"

Phrase: "have"

Phrase: "a differential effect in APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "homozygous genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0019904:homozygous genotype [Organism Attribute]
   861   C0017431:Genotypes [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.83: (iii) the effect of the cis mutation in heterozygous individuals will depend on the phase of this polymorphism with the APOE [epsis] alleles (i.e., the haplotype). 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "the effect of the cis mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in heterozygous individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "will"

Phrase: "depend on the phase of this polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0032529:Polymorphism [Genetic Function]
   748   C0205390:Phase [Temporal Concept]
   748   C0725813:depend [Medical Device]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "] alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "(i.e.,"

Phrase: "the haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.84: In heterozygous Th1/E47cs and APOE [epsis]4 genotype bearers, the [epsis]4 allele may be combined either with the Th1/E47cs T or G allele. 

Phrase: "In heterozygous Th1/E47cs"

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 genotype bearers,"

Phrase: "the [epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "either with the Th1/E47cs T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1423842:TH1 [Gene or Genome]
   753   C3540579:TH1 [Gene or Genome]

Phrase: "or"

Phrase: "G allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.85: One of these combinations may increase the relative expression level of the [epsis]4 allele and decrease the relative expression level of the [epsis]3 allele, the other combination having the inverse influence. 

Phrase: "One of these combinations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the relative expression level of the [epsis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the relative expression level of the [epsis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "]3 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "the"

Phrase: "other combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "having"

Phrase: "the inverse influence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0021399:influential [Idea or Concept]
Processing 00000000.tx.86: Thus, in the [epsis]3/[epsis]4 genotype bearers, the risk of developing AD will be different between the Th1/E47cs heterozygous and homozygous individuals. 

Phrase: "Thus,"

Phrase: "in the [epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 genotype bearers,"

Phrase: "the risk of developing AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "will"

Phrase: "be"

Phrase: "different between the Th1/E47cs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "homozygous individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.87: To test these assumptions, we studied the gender and age adjusted OR for developing AD for Th1/E47cs heterozygous genotype bearers compared with homozygous Th1/E47cs individuals. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "these assumptions,"

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "age adjusted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001779:Age [Organism Attribute]
   861   C0456081:Adjusted [Functional Concept]

Phrase: "OR for developing AD"

Phrase: "for Th1/E47cs heterozygous genotype bearers"

Phrase: "compared with homozygous Th1/E47cs individuals."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0019904:Homozygous [Organism Attribute]
   753   C1423842:TH1 [Gene or Genome]
   753   C1707455:Compared [Activity]
   753   C3540579:TH1 [Gene or Genome]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]
Processing 00000000.tx.88: The Th1/E47cs heterozygous genotype was only associated with an increased risk of developing AD in the heterozygous APOE individuals (OR = 2.40, CI 95% [1.40-4.12], P = 0.001) and not in the homozygous APOE individuals (OR = 1.02, CI 95% [0.67-1.57], P = 0.91). 

Phrase: "The Th1/E47cs heterozygous genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019425:heterozygous genotype [Organism Attribute]
   812   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "associated with an increased risk of developing AD"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the heterozygous APOE individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0027361:Individual [Population Group]
   771   C0237401:Individual [Human]
   717   C1412481:Apolipoprotein E gene [Gene or Genome]

Phrase: "(OR = 2.40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "CI 95%"

Phrase: "[1.40-4.12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439509:/40 [Temporal Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "],"

Phrase: "P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "not in the homozygous APOE individuals"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C1412481:Apolipoprotein E gene [Gene or Genome]
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1445865:Apolipoprotein gene [Gene or Genome]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0019904:Homozygous [Organism Attribute]
   744   C1518422:Not [Functional Concept]
   711   C0027361:Individual [Population Group]
   711   C0237401:Individual [Human]

Phrase: "(OR = 1.02,"

Phrase: "CI 95%"

Phrase: "[0.67-1.57"

Phrase: "],"

Phrase: "P = 0.91"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.89: In particular, in the [epsis]3/[epsis]4 sub-population (Table 5), the risk of developing AD for the heterozygous Th1/E47cs individuals was increased compared with the homozygous Th1/E47cs individuals (OR = 1.90, CI 95% [0.97-3.70], P = 0.06, AD = 107 and Controls = 54). 

Phrase: "In particular,"

Phrase: "in the [epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 sub-population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032659:Population [Quantitative Concept]
   827   C0542339:Sub- [Spatial Concept]
   827   C1257890:Population [Population Group]
   827   C1264637:SUB [Quantitative Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the risk of developing AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "for the heterozygous Th1/E47cs individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "compared with the homozygous Th1/E47cs individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0019904:Homozygous [Organism Attribute]
   748   C1423842:TH1 [Gene or Genome]
   748   C1707455:Compared [Activity]
   748   C3540579:TH1 [Gene or Genome]
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: "(OR = 1.90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439083:>90 [Quantitative Concept]
   827   C0439087:<90 [Quantitative Concept]

Phrase: "CI 95%"

Phrase: "[0.97-3.70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439073:97 [Intellectual Product]
   812   C0439082:>97 [Quantitative Concept]

Phrase: "],"

Phrase: "P = 0.06,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "AD = 107"

Phrase: "and"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "= 54"

Phrase: ")."
Processing 00000000.tx.90: This increased risk became significant in a larger [epsis]3/[epsis]4 population (OR = 2.07, 95% CI [1.21-3.54], P = 0.008, AD = 152 and Controls = 91). 

Phrase: "This increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "became"

Phrase: "significant in a larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(OR = 2.07,"

Phrase: "95% CI [1.21-3.54"

Phrase: "],"

Phrase: "P = 0.008,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "AD = 152"

Phrase: "and"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "= 91"

Phrase: ")."
Processing 00000000.tx.91: However the risk obtained for the heterozygous 1E1 individuals was not significant compared to the homozygous 1E1 individuals (OR = 0.62, 95% CI [0.36; 1.05], P = 0.07). 

Phrase: "However"

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "obtained for the heterozygous 1E1 individuals"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0019425:Heterozygous [Organism Attribute]
   753   C1301820:Obtained [Functional Concept]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]
   719 E C1706701:Obtain [Activity]

Phrase: "was"

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "compared to the homozygous 1E1 individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0019904:Homozygous [Organism Attribute]
   753   C1707455:Compared [Activity]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "(OR = 0.62,"

Phrase: "95% CI [0.36"

Phrase: "; 1.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "],"

Phrase: "P = 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.92: To assess the contribution of each polymorphism on the risk of developing AD in the [epsis]3/[epsis]4 population, we performed a multiple logistic regression. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the contribution of each polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "on the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of developing AD"

Phrase: "in the [epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a multiple logistic regression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0681923:multiple regression [Qualitative Concept]
   901   C0206031:Logistic Regression [Research Activity]
   827   C0242415:logistic [Occupational Activity]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
Processing 00000000.tx.93: We detected an increased risk tendency for developing AD only in the heterozygous Th1/E47cs (OR = 1.89 CI 95% [1.07-3.35], P = 0.027) but not in the heterozygous 1E1 bearers (OR = 0.75, 95% CI [0.43-1.33], P = 0.33). 

Phrase: "We"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "an increased risk tendency for developing AD only"

Phrase: "in the heterozygous Th1/E47cs"

Phrase: "(OR = 1.89 CI 95%"

Phrase: "[1.07-3.35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "],"

Phrase: "P = 0.027"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "not in the heterozygous 1E1 bearers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0019425:Heterozygous [Organism Attribute]
   753   C1518422:Not [Functional Concept]

Phrase: "(OR = 0.75,"

Phrase: "95% CI [0.43-1.33"

Phrase: "],"

Phrase: "P = 0.33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.94: Altogether, these data suggest that the Th1/E47cs polymorphism could modify the relative level of expression of the APOE alleles. 

Phrase: "Altogether,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "could"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the relative level of expression of the APOE alleles."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C3244092:expression level [Idea or Concept]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1547707:Level [Geographic Area]
   738   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.95: Table 5. 

Phrase: "Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.96: . Distribution of the 1E1 and Th1/E47cs genotypes in the larger [epsis]3/[epsis]4 population  1E1 polymorphisma >Th1/E47cs polymorphismb  n GG GC GG GT TT Control cases 91 50 41 16 38 37 AD cases 152 67 85 19 89 44 aP = 0.10; 

Phrase: ". Distribution of the 1E1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "Th1/E47cs genotypes in the larger"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotypes [Organism Attribute]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 population  1E1 polymorphisma"

Phrase: ">Th1/E47cs polymorphismb  n GG GC GG GT TT Control cases 91 50 41 16 38 37 AD cases 152 67 85 19 89 44 aP = 0.10"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   825   C0090566:16-AP [Lipid]
   805   C1522691:GT 41 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   801   C0648082:AD 19 [Organic Chemical,Pharmacologic Substance]
   789   C0052141:AP 10 [Organic Chemical,Pharmacologic Substance]
   781   C0018370:GG [Geographic Area]
   781   C0243148:control [Qualitative Concept]
   781   C0868928:Cases [Functional Concept]
   781   C1423842:TH1 [Gene or Genome]
   781   C1533148:Cases [Quantitative Concept]
   781   C1550141:Control [Substance]
   781   C1882979:Control [Conceptual Entity]
   781   C2587213:Control [Functional Concept]
   781   C3274648:Control [Qualitative Concept]
   781   C3537453:GC [Gene or Genome]
   781   C3540579:TH1 [Gene or Genome]
   748 E C1706255:CASE [Medical Device]
   748 E C1706256:Case [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.97: bP = 0.04. 

Phrase: "bP = 0.04."
Processing 00000000.tx.98: No 1E1 CC genotype was found. 

Phrase: "No 1E1 CC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.99: In order to approach the influence of the phase of the Th1/E47cs and APOE polymorphisms on the AD risk, we estimated the frequencies of the haplotypes with the Th1/E47cs T or G allele associated with the [epsis]4 allele in the AD or controls [epsis]3/[epsis]4 bearer populations (as described in Materials and Methods). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "the influence of the phase of the Th1/E47cs"

Phrase: "and"

Phrase: "APOE polymorphisms on the AD risk,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "the frequencies of the haplotypes"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "with the Th1/E47cs T"

Phrase: "or"

Phrase: "G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "associated with the [epsis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]4 allele in the AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "or"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 bearer populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "("

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: For the APOE [epsis]3/[epsis]4 and Th1/E47cs G/T bearers, 57.6% of the controls were estimated to have the [epsis]4 and T alleles on the same chromosome, while this proportion was 69.7% in the case group, leading to an estimated OR of 1.7. 

Phrase: "For the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and"

Phrase: "Th1/E47cs G/T bearers,"

Phrase: "57.6% of the controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "the [epsis"

Phrase: "]4"

Phrase: "and"

Phrase: "T alleles on the same chromosome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "while"

Phrase: "this proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709707:Proportion [Quantitative Concept]
   928 E C0205351:Proportional [Qualitative Concept]

Phrase: "was"

Phrase: "69.7% in the case group,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0441833:Group [Idea or Concept]
   753   C0450388:69 [Intellectual Product]
   753   C0687744:group [Population Group]
   753   C0868928:Case [Functional Concept]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "leading to an estimated"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C0750572:Estimated [Quantitative Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "OR of 1.7."
Processing 00000000.tx.101: DISCUSSION Recently, the hypothesis of other(s) mutation(s) nearby the APOE gene was fuelled by new physiological data: a difference in the allelic expression of the APOE gene was observed (19), suggesting that non-coding polymorphism(s) in the regulatory regions of the APOE gene could modify the risk of developing AD. 

Phrase: "DISCUSSION Recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "the hypothesis of other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512571:Hypothesis [Idea or Concept]

Phrase: "("

Phrase: "s)"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "s)"

Phrase: "nearby"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706276:Nearby [Qualitative Concept]

Phrase: "the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "was"

Phrase: "fuelled by new physiological data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205314:New [Temporal Concept]
   760   C0205463:Physiological [Functional Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
   726   C0556991:Fuel [Manufactured Object]

Phrase: ":"

Phrase: "a difference in the allelic expression of the APOE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1519516:Differential Gene Expression [Genetic Function]
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that non-coding polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "s) in the regulatory regions of the APOE gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   775   C1412481:Apolipoprotein E gene [Gene or Genome]
   756   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   754   C0017362:Regulatory Gene [Gene or Genome]
   754   C1445865:Apolipoprotein gene [Gene or Genome]
   738   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0017337:Gene [Gene or Genome]
   738   C0220905:regulatory [Regulation or Law]
   738   C1704735:Regulatory [Conceptual Entity]
   738   C2603362:S' [Clinical Attribute]
   704   C0017446:Region [Geographic Area]
   704   C0205147:Region [Spatial Concept]

Phrase: "could"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the risk of developing AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.102: Looking for such new polymorphisms, we found a (G[rarr]T) polymorphism located at position +7 of a degenerative E-box consensus (Fig. 1) (23), that influenced the effect of APOE polymorphisms on AD in the expected way. 

Phrase: "Looking for such new polymorphisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0233426:look [Organism Attribute]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a (G[rarr"

Phrase: "]T) polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "located at position +7 of a degenerative E-box consensus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0011164:Degenerative [Pathologic Function]
   739   C0179400:Box [Manufactured Object]
   739   C0376298:Consensus [Social Behavior]
   739   C0733755:Position [Spatial Concept]
   739   C1533124:Box [Medical Device]
   739   C1880269:Degenerative [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "influenced"

Phrase: "the effect of APOE polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on AD"

Phrase: "in the expected way."
Processing 00000000.tx.103: The Th1/E47cs and 1E1 polymorphisms were associated with AD when studied separately. 

Phrase: "The Th1/E47cs"

Phrase: "and"

Phrase: "1E1 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "when"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "separately."
Processing 00000000.tx.104: Although a strong linkage disequilibrium existed between the [epsis]4, Th1/E47cs T and 1E1 G alleles, the effect of each of these polymorphisms persisted when introduced in the same logistic regression model. 

Phrase: "Although"

Phrase: "a strong linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "existed between the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2987476:Exist [Conceptual Entity]

Phrase: "]4,"

Phrase: "Th1/E47cs T"

Phrase: "and"

Phrase: "1E1 G alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "the effect of each of these polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "persisted"

Phrase: "when"

Phrase: "introduced in the same logistic regression model."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0206031:Logistic Regression [Research Activity]
   774   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   748   C0242415:logistic [Occupational Activity]
   748   C0445247:Same [Qualitative Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C3161035:Model [Intellectual Product]
   714   C1292748:introduce [Functional Concept]
Processing 00000000.tx.105: This observation suggested that the risk associated with the APOE [epsis] alleles may be modulated according to their combination with other polymorphisms. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the APOE"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1412481:Apolipoprotein E gene [Gene or Genome]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C1445865:Apolipoprotein gene [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[epsis"

Phrase: "] alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "modulated according to their combination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205195:Combination [Qualitative Concept]
   760   C0443264:Modulated [Spatial Concept]
   760   C0680240:according [Social Behavior]
   760   C1947911:Combination [Physical Object]

Phrase: "with other polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.106: To have at least one Th1/E47cs T or 1E1 C allele significantly modified the risk of developing AD in the whole population. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have at least one Th1/E47cs T"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205447:One [Quantitative Concept]
   748   C1423842:TH1 [Gene or Genome]
   748   C3154893:Have [Idea or Concept]
   748   C3539897:Have [Qualitative Concept]
   748   C3540579:TH1 [Gene or Genome]

Phrase: "or"

Phrase: "1E1 C allele significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "the risk of developing AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in the whole population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.107: Furthermore, the impact of the [epsis]4 allele seemed decreased, suggesting that part of its effect may be attributed to the promoter polymorphisms. 

Phrase: "Furthermore,"

Phrase: "the impact of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "seemed"

Phrase: "decreased,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that part of its effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "attributed to the promoter polymorphisms."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.108: Another argument was brought forward when estimating the risk associated with the phase. 

Phrase: "Another argument"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680226:argument [Social Behavior]
  1000   C1704769:Argument [Conceptual Entity]

Phrase: "was"

Phrase: "brought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332302:brought [Functional Concept]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "when"

Phrase: "estimating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimating [Quantitative Concept]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with the phase."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205390:Phase [Temporal Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.109: The estimated risk of developing the disease for the [epsis]3/[epsis]4 genotype bearers was not similar according to the combination of the Th1/E47cs and APOE [epsis] alleles on the same chromosome. 

Phrase: "The estimated risk of developing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1519101:Risk Estimate [Quantitative Concept]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "the disease for the [epsis"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 genotype bearers"

Phrase: "was"

Phrase: "not similar according to the combination of the Th1/E47cs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "] alleles on the same chromosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.110: These results were in accordance with our previous data which suggest that the [epsis]3/[epsis]4 individuals will preferentially develop AD, because they expressed the [epsis]4 allele at a greater level. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were in accordance with our previous data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205156:Previous [Temporal Concept]
   748   C1511726:Data [Idea or Concept]
   748   C1552607:previous [Temporal Concept]
   748   C3245479:data [Medical Device]

Phrase: "which"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the [epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "will"

Phrase: "preferentially"

Phrase: "develop"

Phrase: "AD,"

Phrase: "because"

Phrase: "they"

Phrase: "expressed"

Phrase: "the [epsis"

Phrase: "]4 allele at a greater level."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.111: Thus, a cis mutation in the APOE promoter, may favour the relative expression level of the [epsis]4 allele, and potentially the deleterious action of the E4 isoform. 

Phrase: "Thus,"

Phrase: "a cis mutation in the APOE promoter,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0596611:Gene Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "favour"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the relative expression level of the [epsis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "]4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "potentially"

Phrase: "the deleterious action of the E4 isoform."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]
Processing 00000000.tx.112: The Th1/E47cs polymorphism was characterised into a binding site of the basic helix-loop-helix transcription factor, E47. 

Phrase: "The Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "characterised into a binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "of the basic helix-loop-helix transcription factor,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0282642:helix loop helix [Spatial Concept]
   827   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018882:Helix [Eukaryote]
   799   C0040649:Transcription [Genetic Function]
   799   C0229304:Helix [Body Part, Organ, or Organ Component]
   799   C0419518:Loop [Medical Device]
   799   C0445022:Loop [Spatial Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1527178:Basic [Functional Concept]
   799   C1704821:Helix [Spatial Concept]
   799   C1705682:Helix [Anatomical Structure]
   799   C2827422:Factor [Conceptual Entity]
   727 E C0920750:basicity [Quantitative Concept]

Phrase: "E47."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]
Processing 00000000.tx.113: This factor E47 belongs to the class A proteins which are ubiquitously expressed and form combinatorial interactions with the class B proteins to control tissue-specific gene expression (24). 

Phrase: "This factor E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: "belongs to the class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "A proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "are"

Phrase: "ubiquitously"

Phrase: "expressed"

Phrase: "and"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "combinatorial interactions with the class B proteins to control tissue-specific gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   732   C0596610:gene interaction [Genetic Function]
   732   C0872079:interactions protein [Molecular Function]
   732   C1707503:Control Interaction [Molecular Function]
   702   C1704675:Interaction [Functional Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.114: In particular, E47 is expressed in brain, associated with multiple class B protein and is implicated in the development and maintenance of the mammalian nervous system (25-27). 

Phrase: "In particular, E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: "is"

Phrase: "expressed in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "associated with multiple class B protein"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "is"

Phrase: "implicated in the development"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "maintenance of the mammalian nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024501:Maintenance [Activity]

Phrase: "(25-27"

Phrase: ")."
Processing 00000000.tx.115: Little is known about the Th1 factor. 

Phrase: "Little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the Th1 factor."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205309:Known [Qualitative Concept]
   760   C1423842:TH1 [Gene or Genome]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]
   760   C3540579:TH1 [Gene or Genome]
Processing 00000000.tx.116: It was identified in a screen of a mouse embryo cDNA library. 

Phrase: "It"

Phrase: "was"

Phrase: "identified in a screen of a mouse embryo cDNA library."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0013935:Embryo [Embryonic Structure]
   739   C0023621:Library [Manufactured Object,Organization]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0205396:Identified [Qualitative Concept]
   739   C0220908:screen [Health Care Activity]
   739   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C1305370:Embryo [Embryonic Structure]
   739   C1305399:screen [Functional Concept]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   739   C1705053:Screen [Medical Device]
Processing 00000000.tx.117: Its homologous protein in Drosophila is a partner for the Drosophila class A protein daughterless, expression of which is essential for neurogenesis (28). 

Phrase: "Its homologous protein in Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1512488:Homologous Protein [Amino Acid, Peptide, or Protein]
   797   C0949989:Drosophila Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a partner for the Drosophila class"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0682323:Partner [Family Group]

Phrase: "A protein daughterless, expression of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "essential for neurogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.118: Nevertheless it is essential to determine, in vitro and in vivo, the functionality of this transcriptional factor sequence binding. 

Phrase: "Nevertheless"

Phrase: "it"

Phrase: "is"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "determine"

Phrase: ","

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the functionality of this transcriptional factor sequence binding."
Processing 00000000.tx.119: Furthermore, the effect of this new polymorphism susceptible to modulate the risk associated to the APOE alleles must be confirmed by other epidemiological studies and a more profound analysis will have to be performed to determine the haplotypes. 

Phrase: "Furthermore,"

Phrase: "the effect of this new polymorphism susceptible to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated to the APOE alleles"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   814   C1412481:Apolipoprotein E gene [Gene or Genome]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1445865:Apolipoprotein gene [Gene or Genome]
   748   C0002085:Alleles [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Gene [Gene or Genome]
   748   C0332281:Associated [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "must"

Phrase: "be"

Phrase: "confirmed by other epidemiological studies"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002783:Epidemiological Studies [Research Activity]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "a more profound analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "will"

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.120: In conclusion, The Th1/E47cs polymorphism, located within a putative regulatory element of the APOE promoter could contribute to the APOE expression level but other polymorphisms in the regulatory sequences of this gene may exist and a more extended screening of these regulatory regions needs to be developed. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "The Th1/E47cs polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "located within a putative regulatory element of the APOE promoter"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C1412481:Apolipoprotein E gene [Gene or Genome]
   753   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   751   C0003592:Apolipoprotein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0017362:Regulatory Gene [Gene or Genome]
   751   C0314621:Promoter gene [Gene or Genome]
   751   C1445865:Apolipoprotein gene [Gene or Genome]
   736   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0013879:Element [Element, Ion, or Isotope]
   736   C0017337:Gene [Gene or Genome]
   736   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0220905:regulatory [Regulation or Law]
   736   C1704735:Regulatory [Conceptual Entity]
   736   C1705248:Element [Conceptual Entity]

Phrase: "could"

Phrase: "contribute to the APOE expression level"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C1412481:Apolipoprotein E gene [Gene or Genome]
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0017262:Gene Expression [Genetic Function]
   770   C3244092:expression level [Idea or Concept]
   767   C1445865:Apolipoprotein gene [Gene or Genome]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C1880177:Contribute [Activity]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "other polymorphisms in the regulatory sequences of this gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0678951:gene polymorphisms [Genetic Function]
   742   C0032529:polymorphisms [Genetic Function]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "screening of these regulatory regions"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0220905:regulatory [Regulation or Law]
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1704735:Regulatory [Conceptual Entity]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
   726 E C1305399:screen [Functional Concept]
   726 E C1705053:Screen [Medical Device]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "developed."
Processing 00000000.tx.121: The regulation of the APOE gene could be very important for deciphering the mechanisms of the involvement of the APOE alleles, in particular to better define subjects at higher risk of developing AD. 

Phrase: "The regulation of the APOE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0017263:Gene Regulation [Genetic Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "very important for deciphering"

Phrase: "the mechanisms of the involvement of the APOE alleles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0441712:Mechanisms [Functional Concept]
   704 E C1706376:Mechanism [Manufactured Object]

Phrase: "in particular to better"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0332272:Better [Qualitative Concept]
   793 E C0205170:Well [Qualitative Concept]
   793 E C3146287:Well [Manufactured Object]

Phrase: "define"

Phrase: "subjects at higher risk of developing AD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]
Processing 00000000.tx.122: POPULATION AND METHODS Populations The AD and control samples were Caucasian originating from France. 

Phrase: "POPULATION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "AND"

Phrase: "METHODS Populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "The AD"

Phrase: "and"

Phrase: "control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "Caucasian originating from France."
Processing 00000000.tx.123: Sixteen cases were from other European countries. 

Phrase: "Sixteen cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "were from other European countries."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0454713:European country [Geographic Area]
   760   C0239307:European [Population Group]
   760   C0454664:Countries [Geographic Area]
   760   C1535514:European [Population Group]
Processing 00000000.tx.124: These different ethnic origins did not influence genotype distributions. 

Phrase: "These different ethnic origins"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   901   C0015031:Ethnic Origins [Population Group]
   827   C0079946:origins [Classification]
   827   C0439659:Origins [Temporal Concept]
   793 E C1550512:origin [Intellectual Product]
   755 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   755 E C0314603:Genetic [Functional Concept]
   743 E C0205313:Original [Idea or Concept]
   743 E C2347409:Original [Occupational Activity]
   734 E C0005615:Birth [Organism Function]
   734 E C0035150:Reproduction [Organism Function]
   734 E C1550722:birth [Idea or Concept]
   734 E C3245487:birth [Intellectual Product]
   721 E C0454729:Natal [Geographic Area]
   721 E C0559522:Genital [Body System]
   721 E C0598240:originality [Mental Process]
   721 E C1546649:Genital [Intellectual Product]
   721 E C1550642:Genital [Body Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "genotype distributions."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]
Processing 00000000.tx.125: Diagnoses of probable AD were established according to the DSM-III-R and NINCS-ADRDA criteria (n = 293; age = 74.6  9.3, range 51-98; age of onset = 71.02  8.9, range 49-94; 32.2% of men) (29,30). 

Phrase: "Diagnoses of probable AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C0332148:Probable diagnosis [Qualitative Concept]
   770   C0011900:Diagnoses [Finding]
   737 E C1704338:diagnosis [Qualitative Concept]
   737 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "established according to the DSM-III-R"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0220951:DSM III-R [Intellectual Product]
   778   C0444969:III/R [Intellectual Product]
   778   C0679229:DSM-III [Intellectual Product]
   748   C0205090:R- [Spatial Concept]
   748   C0439070:III [Intellectual Product]
   748   C0443211:Established [Qualitative Concept]
   748   C0680240:according [Social Behavior]
   748   C0684010:R. [Professional or Occupational Group]
   748   C1272684:Established [Qualitative Concept]
   748   C1705160:III [Qualitative Concept]
   748   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "NINCS-ADRDA criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "(n = 293"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; age = 74.6  9.3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0001779:Age [Organism Attribute]

Phrase: "range 51-98"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "; age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "= 71.02  8.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450389:71 [Intellectual Product]

Phrase: "range 49-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "; 32.2% of men) (29,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0025268:MEN 2 [Neoplastic Process]
   760   C0025266:Men [Population Group]
   726 E C0024554:MAN [Finding]
   726 E C0086418:Man [Human]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.126: The Caucasian controls were defined as subjects without DMS-III-R dementia criteria and with integrity of their cognitive functions (n = 310; age = 73.5  10.9, range 59-105; 37.4% of men). 

Phrase: "The Caucasian controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "defined as subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "without DMS-III-R dementia criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0243161:criteria [Intellectual Product]

Phrase: "and with integrity of their cognitive functions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0392335:Cognitive functions [Mental Process]
   748   C0205266:integrity [Qualitative Concept]
   748   C0542341:Functions [Functional Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1515981:And [Idea or Concept]
   748   C1516691:Cognitive [Functional Concept]
   748   C1947912:Integrity [Qualitative Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "(n = 310"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; age = 73.5  10.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0001779:Age [Organism Attribute]

Phrase: "range 59-105"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "; 37.4% of men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025266:Men [Population Group]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: ")."
Processing 00000000.tx.127: Each individual or their relatives signed an informed consent. 

Phrase: "Each individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "or"

Phrase: "their relatives"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0080103:Relatives [Family Group]
   966 E C0205345:Relative [Qualitative Concept]
   966 E C1547039:*Relative [Quantitative Concept]

Phrase: "signed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1519316:Signed [Intellectual Product]
  1000   C1561610:signed [Idea or Concept]
   966 E C0311392:Sign [Finding]
   966 E C1547188:Sign [Idea or Concept]

Phrase: "an informed consent."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]
Processing 00000000.tx.128: The number of subjects tested for the different polymorphisms varied as followed: Th1/E47cs study, 279 AD cases and 310 controls; 

Phrase: "The number of subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "tested for the different polymorphisms"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0392366:tested [Intellectual Product]
   760   C1705242:Different [Qualitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "varied"

Phrase: "as"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Th1/E47cs"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "279 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "310 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.129: 1E1 study, 293 AD cases and 307 controls; 

Phrase: "1E1 study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "293 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "307 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.130: D19S178 study, 272 AD cases and 279 controls. 

Phrase: "D19S178 study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "272 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "279 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.131: In order to increase the statistical power of the study for further analysis in heterozygous individuals, we increased the number of individuals with the [epsis]3/[epsis]4 genotype adding new [epsis]3/[epsis]4 subjects from independent populations, up to a total of 152 AD and 91 control cases (73.3  8.5 and 70.3  8.5 years, respectively). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the statistical power of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0814897:Statistical Power [Research Activity]
   753   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "for further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "in heterozygous individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "we"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the number of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "with the [epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "new"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 subjects from independent populations,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "up to a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 152 AD"

Phrase: "and"

Phrase: "91 control cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "(73.3  8.5"

Phrase: "and"

Phrase: "70.3  8.5 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.132: Sequencing Direct sequencing was performed with the 70770 sequenase version 2.0 DNA sequencing kit (Amersham Life Science) using [[gamma]-35S]dATP. 

Phrase: "Sequencing"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162326:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]

Phrase: "Direct sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with the 70770 sequenase version 2.0 DNA sequencing kit (Amersham Life Science"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   801   C0005526:Science, Life [Occupation or Discipline]
   788   C0036397:Science [Occupation or Discipline]
   788   C0376558:Life [Idea or Concept]
   705 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "["

Phrase: "[gamma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017011:Gamma [Natural Phenomenon or Process]
  1000   C1552644:Gamma [Intellectual Product]
  1000   C2349976:Gamma [Quantitative Concept]

Phrase: "]-35S"

Phrase: "]dATP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045186:dATP [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.133: APOE PCR products were obtained as described in ASO technique (see below). 

Phrase: "APOE PCR products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   836   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   836   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C1412481:Apolipoprotein E gene [Gene or Genome]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "as"

Phrase: "described in ASO technique"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0002085:Allele [Gene or Genome]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205369:Specific [Qualitative Concept]
   753   C0449851:Technique [Functional Concept]
   753   C1552738:described [Idea or Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.134: Reactions were run on a 6% acrylamide/8 M urea gel for 1-2 h under 60 W. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "a 6% acrylamide/8 M urea gel for 1-2 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0017243:Gel [Biomedical or Dental Material]
   738   C1382104:Gel [Substance]

Phrase: "under 60 W."
Processing 00000000.tx.135: The gels were then exposed to X-ray film. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to X-ray film."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C0043303:X-Ray Film [Medical Device]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0086296:Film [Manufactured Object]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C1561571:film [Biomedical or Dental Material]
   760   C1561572:film [Substance]
   760   C2314876:ray [Fish]
Processing 00000000.tx.136: Genetic analysis Genomic DNA was extracted from white blood cells. 

Phrase: "Genetic analysis Genomic DNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0683227:genetic dna [Genetic Function]
   875   C0200898:analysis dna [Laboratory Procedure]
   861   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017428:Genomic [Gene or Genome]
   812   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "extracted from white blood cells."
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   862   C0023508:White Blood Cells [Laboratory Procedure]
   862   C0023516:White Blood Cells [Cell]
           White Cell
   806   C0005773:Blood Cells [Cell]
   762 E C2328697:Hemal cell [Cell]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0007457:White [Population Group]
   760   C0007634:Cells [Cell]
   760   C0043157:White [Population Group]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0220938:White [Qualitative Concept]
   760   C0229664:Blood [Body Substance]
   760   C3282337:Cells [Cell]
   760   C3541890:EXTRACTED [Finding]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2828366:Extract [Substance]
Processing 00000000.tx.137: We analysed the Th1/E47cs polymorphism distribution together with two other polymorphisms located in the 19q13.2 chromosomal region flanking the Th1/E47cs polymorphism: the 1E1 polymorphism located 1.15 kb downstream of the Th1/E47cs polymorphism and the anonymous (CA)n repeat DNA marker, D19S178 located ~2.4 cM upstream of the APOE gene. 

Phrase: "We"

Phrase: "analysed"

Phrase: "the Th1/E47cs polymorphism distribution together with two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "other polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "located in the 19q13.2 chromosomal region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1520860:19q13.2 [Cell Component]
   778   C1953345:Chromosomal region [Cell]
   748   C0008633:Chromosomal [Cell Component]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C1520855:19q13 [Cell Component]
   738   C0008662:Chromosome 2 [Cell Component]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "the 1E1 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "located"

Phrase: "1.15 kb downstream of the Th1/E47cs polymorphism"

Phrase: "and"

Phrase: "the anonymous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2346787:Anonymous [Qualitative Concept]
  1000   C3245483:Anonymous [Intellectual Product]

Phrase: "(CA)n repeat DNA marker,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0012872:Marker, DNA [Nucleotide Sequence]
   804   C0005516:Marker [Clinical Attribute]

Phrase: "D19S178"

Phrase: "located"

Phrase: "~2.4 cM upstream of the APOE gene."
Processing 00000000.tx.138: The frequency of the D19S178 repeat alleles were dichotomised in long (167 and over) and short alleles (5). 

Phrase: "The frequency of the D19S178 repeat alleles"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0017270:Allele Frequency [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "dichotomised in long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205166:Long [Qualitative Concept]
   790   C1706317:Long [Qualitative Concept]

Phrase: "(167"

Phrase: "and"

Phrase: "over"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "short alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: The four markers were amplified by polymerase chain reaction in a Perkin-Elmer Cetus thermal cycler. 

Phrase: "The four markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "amplified by polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "in a Perkin-Elmer Cetus thermal cycler."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C1611676:Thermal Cycler [Medical Device]
Processing 00000000.tx.140: The anonymous (CA)n repeat DNA marker, D19S178, the 1E1 polymorphism and the APOE polymorphism were tested as previously described (8,22,31). 

Phrase: "The anonymous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2346787:Anonymous [Qualitative Concept]
  1000   C3245483:Anonymous [Intellectual Product]

Phrase: "(CA)n repeat DNA marker,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0012872:Marker, DNA [Nucleotide Sequence]
   804   C0005516:Marker [Clinical Attribute]

Phrase: "D19S178,"

Phrase: "the 1E1 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the APOE polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0678951:gene polymorphism [Genetic Function]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]
   756   C1412481:Apolipoprotein E gene [Gene or Genome]
   708   C1445865:Apolipoprotein gene [Gene or Genome]

Phrase: "were"

Phrase: "tested as previously"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(8,"

Phrase: "22,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: Because the Th1/E47cs polymorphism did not create or destroy any restriction enzyme sites, two techniques were used to confirm the results. 

Phrase: "Because"

Phrase: "the Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "or"

Phrase: "destroy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681205:Destroy [Idea or Concept]

Phrase: "any restriction enzyme sites,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C1882940:Restriction Enzyme Site [Nucleotide Sequence]
           Restriction Site
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
   734   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "two techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.142: The first one consisted of designing a mismatch primer which contained one mismatched base pair, four bases away from the 3[prime] end of the forward primer and five bases from the polymorphism. 

Phrase: "The first one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "consisted of designing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "a mismatch primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "one mismatched base pair,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0600436:Base Pair [Molecular Function]
   812   C0002055:base [Inorganic Chemical]
   812   C0178499:Base [Chemical Viewed Functionally]
   812   C1709450:Pair [Qualitative Concept]
   812   C1880279:Base [Biomedical or Dental Material]
   741 E C0205112:Basal [Spatial Concept]
   729 E C0016617:Foundation [Organization]
   729 E C1626935:Bases [Quantitative Concept]

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "bases away from the 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002055:base [Inorganic Chemical]
   760   C0178499:Base [Chemical Viewed Functionally]
   760   C1626935:Bases [Quantitative Concept]
   760   C1880279:Base [Biomedical or Dental Material]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "end of the forward primer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1953382:Forward primer [Cell]
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439780:Forward [Spatial Concept]
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "five bases from the polymorphism."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0178499:bases [Chemical Viewed Functionally]
   760   C1626935:Bases [Quantitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C1527178:Basis [Functional Concept]
   726 E C1874451:Basis [Pharmacologic Substance]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.143: When incorporated into a PCR product, this primer produced a Bstn I cut site when a G was present and no cut site when a T was present at the polymorphic site. 

Phrase: "When"

Phrase: "incorporated into a PCR product,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "this primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "produced"

Phrase: "a Bstn I cut site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "when"

Phrase: "a G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "no cut site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "when"

Phrase: "a T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "present at the polymorphic site."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.144: Briefly, the PCR step was performed during 40 cycles (1 min at 94C, 1 min 15 s at 54C and 1 min at 72C each cycle) with the forward primer 5[prime]-AGAATGGAGGAGGGTGCCTG-3[prime] and the reverse primer 5[prime]-ACTCAAGGATCCCAGACTTG-3[prime] in a total volume of 50 l containing 1.25 U Taq DNA polymerase, 0.2 mM of each dNTP, 1% of DMSO, 0.5 mM of MgCl2. 

Phrase: "Briefly,"

Phrase: "the PCR step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "performed during 40 cycles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439509:/40 [Temporal Concept]
   770   C0884358:Performed [Functional Concept]
   737   C1511572:Cycle [Temporal Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(1 min at 94C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "1 min 15 s at 54C"

Phrase: "and"

Phrase: "1 min at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "each cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: "with the forward primer 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1953382:Forward primer [Cell]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0439780:Forward [Spatial Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-AGAATGGAGGAGGGTGCCTG-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "and"

Phrase: "the reverse primer 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-ACTCAAGGATCCCAGACTTG-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "in a total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0449468:Total Volume [Quantitative Concept]
           *Volume
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 50 l"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.25 U Taq DNA polymerase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   861   C2257065:Taq DNA polymerase [Genetic Function]
   827   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "0.2 mM of each dNTP,"

Phrase: "1% of DMSO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: "0.5 mM of MgCl2."
Processing 00000000.tx.145: Twenty five l PCR of product was digested with 1 U Bstn I at 60C overnight. 

Phrase: "Twenty five l PCR of product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "digested with 1 U Bstn I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   783   C1425233:I-1 [Gene or Genome]
   783   C3540559:I-1 [Gene or Genome]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0868946:digested [Physiologic Function]

Phrase: "at 60C overnight."
Processing 00000000.tx.146: Digestion products were visualised with a 12% polyacrylamide gel. 

Phrase: "Digestion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "visualised with a 12% polyacrylamide gel."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
Processing 00000000.tx.147: The Th1/E47cs T allele was characterised by a 49 bp fragment and the G allele by a 31 bp fragment. 

Phrase: "The Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "characterised by a 49 bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "the G allele by a 31 bp fragment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.148: The second technique consisted of performing an allele-specific oligonucleotide (ASO) hybridisation. 

Phrase: "The second technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "consisted of performing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0332529:CONSIST [Qualitative Concept]
   756   C0884358:Perform [Functional Concept]
   756   C2947996:Perform [Pharmacologic Substance]

Phrase: "an allele-specific oligonucleotide (ASO) hybridisation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.149: A 375 bp fragment containing the Th1/E47cs polymorphism was amplified using as forward primer: 5[prime]-TACTTTCTTTCTGGGATCCAGG-3[prime] and reverse primer: 5[prime]-ACTCAAGGATCCCAGACTTG-3[prime]. 

Phrase: "A 375 bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Th1/E47cs polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: "using as forward primer"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1953382:Forward primer [Cell]
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439780:Forward [Spatial Concept]
   770   C1524063:Using [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TACTTTCTTTCTGGGATCCAGG-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "and"

Phrase: "reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-ACTCAAGGATCCCAGACTTG-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]."
Processing 00000000.tx.150: PCR was performed in a total volume of 50 l during 35 cycles (1 min at 94C, 1 min at 50C and 1 min at 72C each cycle) containing 1.25 U Taq polymerase, 0.2 mM of each dNTP, 1 mM of MgCl2. 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed in a total volume of 50 l"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0449468:Total Volume [Quantitative Concept]
           *Volume
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "during 35 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(1 min at 94C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "1 min at 50C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "1 min at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "each cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.25 U Taq polymerase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "0.2 mM of each dNTP,"

Phrase: "1 mM of MgCl2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1418486:MM-1 [Gene or Genome]
Processing 00000000.tx.151: The two primers: 5[prime]-GCCCAGTAATCCAGACACCC-3[prime] and 5[prime]-GCCCAGTAATACAGACACCC-3[prime] (for the G and T allele detection, respectively), were 5[prime] end labelled with DIG (Boerhinger Mannheim). 

Phrase: "The two primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-GCCCAGTAATCCAGACACCC-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-GCCCAGTAATACAGACACCC-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "("

Phrase: "for the G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "T allele detection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "] end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "labelled with DIG (Boerhinger Mannheim"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1321878:DIG [Neoplastic Process]
   726   C0181496:Label [Manufactured Object]
   726   C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")."
Processing 00000000.tx.152: Allele-specific hybridisation was obtained after washing for 3 min in a 0.1% SDS and 0.5 SSC solution at 61C and 62C for the G and T allele hybridisation, respectively. 

Phrase: "Allele-specific hybridisation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "was"

Phrase: "obtained after washing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0441648:Washing [Activity]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "for 3 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in a 0.1% SDS"

Phrase: "and"

Phrase: "0.5 SSC solution at 61C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "62C for the G"

Phrase: "and"

Phrase: "T allele hybridisation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "respectively."
Processing 00000000.tx.153: Detection was realised as described by the supplier (Boerhinger Mannheim). 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "realised"

Phrase: "as"

Phrase: "described by the supplier"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0470689:Supplier [Health Care Related Organization]
   770   C0470690:supplier [Health Care Related Organization]
   770   C1552738:described [Idea or Concept]

Phrase: "(Boerhinger Mannheim"

Phrase: ")."
Processing 00000000.tx.154: Statistical analysis The SAS software release 6.10 was used (SAS Institute Inc., Cary, NC, USA). 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "The SAS software release 6.10"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   875   C1822613:SAS-6 [Gene or Genome]
   804   C0030685:Release [Health Care Activity]
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0605290:SAS [Organic Chemical]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1426104:SAS [Gene or Genome]
   804   C1823519:SAS [Gene or Genome]
   804   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(SAS Institute Inc.,"

Phrase: "Cary,"

Phrase: "NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.155: Univariate analysis was performed using Pearson's [chi]2 test and Fisher exact test when necessary. 

Phrase: "Univariate analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683962:univariate analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Pearson's"

Phrase: "[chi]2 test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "and"

Phrase: "Fisher exact test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0325045:Fisher [Mammal]
   827   C0392366:test [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]

Phrase: "when"

Phrase: "necessary."
Processing 00000000.tx.156: Since the impact of the [epsis]4 allele is the more pronounced in a range from 60 to 75 years (32,33) and since no significant difference was observed in the distribution of the different markers according to the age (a cut-off of 65 years was tested), we analysed the different polymorphisms without performing distinction between early and late onset. 

Phrase: "Since"

Phrase: "the impact of the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "the more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced in a range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "from 60"

Phrase: "to 75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(32,"

Phrase: "33"

Phrase: ")"

Phrase: "and"

Phrase: "since"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711239:Since [Temporal Concept]

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed in the distribution of the different markers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0520511:distribution [Idea or Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1704711:Distribution [Functional Concept]
   744   C1705242:Different [Qualitative Concept]
   711   C0005516:Marker [Clinical Attribute]

Phrase: "according to the age ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "a cut-off of 65 years"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442160:Cutoff [Functional Concept]
   753   C0000925:Cut [Injury or Poisoning]
   753   C1883724:CUT [Phenomenon or Process]

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "analysed"

Phrase: "the different polymorphisms without performing distinction"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "between early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late onset."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.157: Deviations from the Hardy-Weinberg equilibrium hypothesis were tested. 

Phrase: "Deviations from the Hardy-Weinberg equilibrium hypothesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0012727:Deviation [Spatial Concept]
   714   C0205419:Deviation [Qualitative Concept]
   714   C1705236:Deviation [Finding]

Phrase: "were"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.158: Pairwise linkage disequilibriums were measured on collapsed data after estimation of two marker haplotype frequencies by the maximum likelihood procedure for D19S178, Th1/E47cs, 1E1 and APOE (coded as biallelic marker, i.e. allele [epsis]4 versus allele [epsis]2 or [epsis]3) (34). 

Phrase: "Pairwise linkage disequilibriums"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0023746:Linkage Disequilibriums [Quantitative Concept]
   793   C0281825:Disequilibrium [Finding]
   793   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "were"

Phrase: "measured on collapsed data"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0344329:collapsed [Finding]
   770   C0392748:Collapsed [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0036974:collapse [Pathologic Function]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0332521:Collapse [Phenomenon or Process]
   737 E C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "after estimation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0680844:estimation [Mental Process]
  1000   C0681916:Estimation [Quantitative Concept]
  1000   C0750572:Estimation [Quantitative Concept]

Phrase: "of two marker haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0439603:Frequencies [Temporal Concept]
   779 E C0376249:frequency [Quantitative Concept]
   779 E C0871396:Frequency [Quantitative Concept]
   779 E C1561548:Frequency [Qualitative Concept]
   779 E C1705502:Frequency [Quantitative Concept]
   729 E C0332183:Frequent [Temporal Concept]

Phrase: "by the maximum likelihood procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "for D19S178,"

Phrase: "Th1/E47cs,"

Phrase: "1E1"

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "coded as biallelic marker,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005516:Marker [Clinical Attribute]
   737   C0009219:code [Occupational Activity]
   737   C0805701:Code [Intellectual Product]

Phrase: "i.e. allele"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "versus"

Phrase: "allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "[epsis"

Phrase: "]2 or [epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.159: The standardised disequilibrium ([delta]) and the percent of the maximum possible value of disequilibrium were computed as outlined by Thompson et al. 

Phrase: "The standardised disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "("

Phrase: "[delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]"

Phrase: ")"

Phrase: "and"

Phrase: "the percent of the maximum possible value of disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439165:Percent [Quantitative Concept]

Phrase: "were"

Phrase: "computed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441526:Computed [Laboratory Procedure]
  1000   C1880157:Computed [Activity]

Phrase: "as"

Phrase: "outlined by Thompson et al."
Processing 00000000.tx.160: (35). 

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.161: Statistical significance for linkage disequilibrium was considered only at P < 0.001 level since multiple non-independent pairwise comparisons were performed. 

Phrase: "Statistical significance for linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "only at P < 0.001 level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205171:Only [Quantitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1720467:Only [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "since"

Phrase: "multiple non-independent pairwise comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.162: Extended haplotype frequencies of the four markers were estimated on collapsed data using the myriad haplotype algorithm described by McLean and Morton (36), implemented in a computer program by Cox et al. 

Phrase: "Extended haplotype frequencies of the four markers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "estimated on collapsed data"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0344329:collapsed [Finding]
   770   C0392748:Collapsed [Functional Concept]
   770   C0750572:Estimated [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0036974:collapse [Pathologic Function]
   737 E C0332521:Collapse [Phenomenon or Process]
   737 E C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the myriad haplotype algorithm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002045:algorithm [Intellectual Product]
   827   C1553907:algorithm [Laboratory Procedure]

Phrase: "described by McLean"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Morton"

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "implemented in a computer program"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0037585:Computer Program [Intellectual Product,Manufactured Object]
   760   C0009622:Computer [Manufactured Object]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "by Cox et al."
Processing 00000000.tx.163: (37). 

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.164: The comparisons between haplotype frequencies in cases and controls were tested with a likelihood ratio test. 

Phrase: "The comparisons between haplotype frequencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "tested with a likelihood ratio test."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   767   C0683443:test test [Diagnostic Procedure]
   753   C0033204:Likelihood [Quantitative Concept]
   753   C0392366:tested [Intellectual Product]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
Processing 00000000.tx.165: The estimated frequencies were compared with those expected on the basis of equilibrium by Pearson's [chi]2 or Fisher exact test as necessary (38). 

Phrase: "The estimated frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "expected on the basis of equilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0014653:Equilibrium [Organism Function]
   753   C1517001:Expected [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1547026:Equilibrium [Quantitative Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "by Pearson's"

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "or"

Phrase: "Fisher exact test as necessary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0325045:Fisher [Mammal]
   760   C0392366:test [Intellectual Product]
   760   C2828393:Exact [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.166: In the multivariate analysis, we coded the genotypes of each subject as dummy variables according to the tested hypotheses (at least one D19S178 short allele: SS+SL versus LL, at least one Th1/E47cs T allele: TT+TG versus GG, at least one 1E1 C allele: CC+GC versus GG and at least one [epsis]4 allele). 

Phrase: "In the multivariate analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026777:Multivariate Analysis [Quantitative Concept]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "coded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0009219:code [Occupational Activity]
   966   C0805701:Code [Intellectual Product]

Phrase: "the genotypes of each subject"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "as dummy variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "according to the tested hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "("

Phrase: "at least one D19S178 short allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "SS+SL"

Phrase: "versus"

Phrase: "LL,"

Phrase: "at least one Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "TT+TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "versus"

Phrase: "GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018370:GG [Geographic Area]

Phrase: "at least one 1E1 C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "CC+GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "versus"

Phrase: "GG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018370:GG [Geographic Area]

Phrase: "and at least one [epsis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205447:One [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.167: The effects of these variables on the disease were tested in a multiple logistic regression model adjusted for age and gender. 

Phrase: "The effects of these variables"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "tested in a multiple logistic regression model"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0206031:Logistic Regression [Research Activity]
   774   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   774   C0681923:multiple regression [Qualitative Concept]
   748   C0242415:logistic [Occupational Activity]
   748   C0392366:tested [Intellectual Product]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C3161035:Model [Intellectual Product]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "adjusted for age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0456081:Adjusted [Functional Concept]

Phrase: "and"

Phrase: "gender."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]
Processing 00000000.tx.168: Estimation of the risk of developing AD according to the combination of the Th1/E47cs T and [epsis]4 alleles in the [epsis]3/[epsis]4 subgroup According to the three polymorphisms presented in Table 3c, we defined in the [epsis]3/[epsis]4 sub-populations: 1 where fi is the frequency of the haplotype i (i = 1-8; as defined in Table 3c), xi is the frequency of the [epsis]3 allele found in the haplotype i and yi, the frequency of the [epsis]4 allele found in the haplotype i. 

Phrase: "Estimation of the risk of developing AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0680844:estimation [Mental Process]
   748   C0681916:Estimation [Quantitative Concept]
   748   C0750572:Estimation [Quantitative Concept]

Phrase: "according to the combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "of the Th1/E47cs T"

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 alleles in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 subgroup According to the three polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1079230:subgroup [Virus]
   748   C1515021:Subgroup [Classification]

Phrase: "presented in Table 3c,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C0450366:3c [Intellectual Product]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "we"

Phrase: "defined in the [epsis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 sub-populations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032659:Population [Quantitative Concept]
   827   C0542339:Sub- [Spatial Concept]
   827   C1257890:Population [Population Group]
   827   C1264637:SUB [Quantitative Concept]

Phrase: ":"

Phrase: "1 where fi"

Phrase: "is"

Phrase: "the frequency of the haplotype i"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018591:Haplotype [Organism Attribute]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "(i"

Phrase: "= 1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"

Phrase: "as"

Phrase: "defined in Table 3c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0450366:3c [Intellectual Product]
   770   C1704788:Defined [Conceptual Entity]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3539106:Defined [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "xi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]

Phrase: "is"

Phrase: "the frequency of the [epsis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "]3 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "found in the haplotype i"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "yi,"

Phrase: "the frequency of the [epsis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "found in the haplotype i."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.169: Because our estimation is performed in the [epsis]3/[epsis]4 sub-population with equal total proportion of [epsis]3 and [epsis]4 alleles, we have: 2 Given that the 1E1 C allele is in strong linkage disequilibrium with the APOE [epsis] polymorphism (Tables 2 and 3) and is only associated with the [epsis]3 allele, y2 = y4 = y6 = y8 = 0. 

Phrase: "Because"

Phrase: "our estimation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0680844:estimation [Mental Process]
  1000   C0681916:Estimation [Quantitative Concept]
  1000   C0750572:Estimation [Quantitative Concept]

Phrase: "is"

Phrase: "performed in the [epsis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 sub-population with equal total proportion of [epsis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C3258257:Total population [Quantitative Concept]
   742   C0032659:Population [Quantitative Concept]
   742   C0542339:Sub- [Spatial Concept]
   742   C1257890:Population [Population Group]
   742   C1264637:SUB [Quantitative Concept]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and ["

Phrase: "epsis"

Phrase: "]4 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "we"

Phrase: "have"

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the 1E1 C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "is in strong linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0442821:Strong [Qualitative Concept]

Phrase: "with the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "] polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Tables 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "associated with the [epsis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]3 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "y2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "= y4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "= y6"

Phrase: "= y8"

Phrase: "= 0."
Processing 00000000.tx.170: Thus, the x2, x4, x6 and x8 values are directly obtained from Table 3c with fi = xi. 

Phrase: "Thus,"

Phrase: "the x2,"

Phrase: "x4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321095:X4 [Quantitative Concept]

Phrase: "x6"

Phrase: "and"

Phrase: "x8 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "obtained from Table 3c"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C0450366:3c [Intellectual Product]
   770   C1301820:Obtained [Functional Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C1706701:Obtain [Activity]

Phrase: "with fi = xi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720296:Xi [Intellectual Product]
Processing 00000000.tx.171: From equation 2, we obtain: and 3 xi can be directly approached with the haplotype distribution estimated in the [epsis]3/[epsis]3 subgroup. 

Phrase: "From equation 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: "we"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: ":"

Phrase: "and"

Phrase: "3 xi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720296:Xi [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "approached with the haplotype distribution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
   726   C0449445:Approach [Spatial Concept]

Phrase: "estimated in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750572:Estimated [Quantitative Concept]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3 subgroup."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1079230:subgroup [Virus]
   861   C1515021:Subgroup [Classification]
Processing 00000000.tx.172: If xi[prime] is the frequency of the haplotype i in the [epsis]3/[epsis]3 AD or control subgroup, the xi value is estimated as follows: 4 and from equation 4: 5 The yi value can be deduced from equation 1. 

Phrase: "If"

Phrase: "xi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "is"

Phrase: "the frequency of the haplotype i"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018591:Haplotype [Organism Attribute]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in the [epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]3 AD"

Phrase: "or"

Phrase: "control subgroup,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1079230:subgroup [Virus]
   861   C1515021:Subgroup [Classification]

Phrase: "the xi value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "4"

Phrase: "and from equation 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0552449:Equation [Conceptual Entity]
   770   C1515981:And [Idea or Concept]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "The yi value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "deduced from equation 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0552449:Equation [Conceptual Entity]
Processing 00000000.tx.173: Thus, we estimated frequency of the four possible phases of the Th1/E47cs G/T and APOE [epsis]3/[epsis]4 heterozygous AD and control sub-populations as follows: [epsis]4 and Th1/E47cs T allele: x1 + x3 [epsis]4 and Th1/E47cs G allele: x2 + x4 [epsis]3 and Th1/E47cs T allele: y1 + y2 + y5 + y6 [epsis]3 and Th1/E47cs G allele: y3 + y4 + y7 + y8 ACKNOWLEDGEMENTS J.C.L. was a recipient of the Ministre d l'Enseignement suprieur et de la Recherche. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "frequency of the four possible phases of the Th1/E47cs G/T"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   736   C0376249:frequency [Quantitative Concept]
   736   C0439603:Frequency [Temporal Concept]
   736   C0871396:Frequency [Quantitative Concept]
   736   C1561548:Frequency [Qualitative Concept]
   736   C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 heterozygous AD"

Phrase: "and"

Phrase: "control sub-populations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0032662:control population [Occupation or Discipline]
   827   C0032659:Population [Quantitative Concept]
   827   C0542339:Sub- [Spatial Concept]
   827   C1257890:Population [Population Group]
   827   C1264637:SUB [Quantitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and"

Phrase: "Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "x1 + x3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421546:X3 [Gene or Genome]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and"

Phrase: "Th1/E47cs G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "x2 + x4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1321095:X4 [Quantitative Concept]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Th1/E47cs T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "y1 + y2 + y5 + y6"

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Th1/E47cs G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "y3 + y4 + y7 + y8 ACKNOWLEDGEMENTS J.C.L."

Phrase: "was"

Phrase: "a recipient of the Ministre d l'Enseignement suprieur et de la"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1709854:Recipient [Human]

Phrase: "Recherche."
Processing 00000000.tx.174: This work was supported by the Institut National de la Sant et de la Recherche Mdicale (INSERM), the Institut Pasteur de Lille (IPL) and the Conseil Rgional du Nord-Pas de Calais `axe rgional de recherche sur les maladies neurodgnratives et le vieillissement crbral' (to P.A., M.C.C.H. and F.P.). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Institut National de la Sant et de la Recherche Mdicale (INSERM),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   735   C0011198:DE [Geographic Area]
   735   C0017480:DE [Geographic Area]
   735   C0023031:La [Element, Ion, or Isotope]
   735   C1521721:Supported [Conceptual Entity]
   735   C3245503:national [Intellectual Product]
   735   C3541240:DE [Idea or Concept]
   702 E C0183683:Support [Medical Device]

Phrase: "the Institut Pasteur de Lille (IPL)"

Phrase: "and"

Phrase: "the Conseil Rgional du Nord-Pas de Calais `axe rgional de recherche sur les maladies neurodgnratives et le vieillissement crbral'"

Phrase: "("

Phrase: "to P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "M.C.C.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "F.P."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.175: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.176: Schellenberg,G., Deeb,S.S., Boehnke,M., Bryant,E.M., Martin,G.M., Lampe,T.H. and Bird,T.H. 

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Deeb,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Boehnke,"

Phrase: "M."

Phrase: ","

Phrase: "Bryant,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Lampe,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.177: (1987) Association of an Apolipoprotein CII allele with familial dementia of the Alzheimer type. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Association of an Apolipoprotein CII allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with familial dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "of the Alzheimer type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.178: J. 

Phrase: "J."
Processing 00000000.tx.179: Neurogenet., 4, 97-108. 

Phrase: "Neurogenet.,"

Phrase: "4,"

Phrase: "97-108."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.180: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.181: Pericak-Vance,M.A., Bedout,J.L., Gaskell,P.C., Yamaoka,L.H., Hung,W-Y., Alberts,M.J., Walker,A.P., Barlett,R.J., Haynes,C.A.,Welsh,K.A., Earl,N.L., Heyman,A., Clark,C.M. and Roses,A.D. 

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bedout,"

Phrase: "J.L., Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Yamaoka,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "W-Y.,"

Phrase: "Alberts,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "A.P.,"

Phrase: "Barlett,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Haynes,"

Phrase: "C.A.,Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0043114:Welsh [Population Group]

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Earl,"

Phrase: "N.L., Heyman,"

Phrase: "A.,"

Phrase: "Clark,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.182: (1991), Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. 

Phrase: "(1991"

Phrase: ")"

Phrase: ","

Phrase: "Linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "studies in familial Alzheimer disease"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0199236:Familial Study [Diagnostic Procedure]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "evidence for chromosome 19 linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.183: Am. 

Phrase: "Am."
Processing 00000000.tx.184: J. 

Phrase: "J."
Processing 00000000.tx.185: Hum. 

Phrase: "Hum."
Processing 00000000.tx.186: Genet., 55, 991-1000. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "991-1000."
Processing 00000000.tx.187: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.188: Schellenberg,G., Boehnke,M., Wijsman,E.M., Moore,D.K., Martin,G.M. and Bird,T.D. 

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Boehnke,"

Phrase: "M."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Martin,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.D."
Processing 00000000.tx.189: (1992), Genetic association and linkage analysis of the apolipoprotein E-CII locus and Familial Alzheimer's disease. 

Phrase: "(1992"

Phrase: ")"

Phrase: ","

Phrase: "Genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "linkage analysis of the apolipoprotein E-CII locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0796345:linkage analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0023745:linkage [Molecular Function]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.190: Ann. 

Phrase: "Ann."
Processing 00000000.tx.191: Neurol., 31, 223-227. 

Phrase: "Neurol.,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "223-227."
Processing 00000000.tx.192: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.193: Strittmatter,W.J, Saunders,A.M, Schmechel,D., Pericak-Vance,M., Englhild,J., Salvesen,O.S. and Roses,A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J,"

Phrase: "Saunders,"

Phrase: "A.M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Englhild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "O.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.194: (1993) Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "high avidity binding to beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1149161:beta-amyloid binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "increased frequency of type 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in late-onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
  1000   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.195: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.196: Natl. 

Phrase: "Natl."
Processing 00000000.tx.197: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.198: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.199: USA, 90, 1977-1981. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1977-1981."
Processing 00000000.tx.200: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.201: Chartier-Harlin,M.-C., Parfitt,M., Legrain,S., Prez-Tur,J., Brousseau,T., Evans,A., Berr,C., Vidal,O., Roques,P., Gourlet,V., Fruchart,J.C., Delacourte,A., Rossor,M. and Amouyel,P. 

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Parfitt,"

Phrase: "M."

Phrase: ","

Phrase: "Legrain,"

Phrase: "S."

Phrase: ","

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Brousseau,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Evans,"

Phrase: "A.,"

Phrase: "Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gourlet,"

Phrase: "V.,"

Phrase: "Fruchart,"

Phrase: "J.C., Delacourte,"

Phrase: "A.,"

Phrase: "Rossor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.202: (1994) Apolipoprotein E [epsis]4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele as a major risk factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "for sporadic early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "forms of Alzheimer's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "analysis of the 19q13.2 chromosomal region."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0853259:chromosomal analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   738 E C0200867:Chromosome analysis [Laboratory Procedure]
Processing 00000000.tx.203: Hum. 

Phrase: "Hum."
Processing 00000000.tx.204: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.205: Genet., 3, 569-574. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "569-574."
Processing 00000000.tx.206: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.207: Van Duijn,C.M., De Kniff,P., Wehnert,A., De Voecht,J., Bronzova,J.B., Havekes,L.M., Hofman,A. and Van Broeckhoven,C. 

Phrase: "Van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "De Kniff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "De Voecht,"

Phrase: "J.,"

Phrase: "Bronzova,"

Phrase: "J.B.,"

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.208: (1995) Reduced survival of patients with early-onset alzheimer's disease that carry the Apolipoprotein E2 allele. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Reduced survival of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "with early-onset alzheimer's disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the Apolipoprotein E2 allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C0052198:Apolipoprotein E2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.209: Ann. 

Phrase: "Ann."
Processing 00000000.tx.210: Neurol., 37, 605-610. 

Phrase: "Neurol.,"

Phrase: "37,"

Phrase: "605-610."
Processing 00000000.tx.211: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.212: Prez-Tur,J., Campion,D., Martinez,M., Brice,A., Tardieu,S., Hannequin,D., Agid,Y., Delacourte,A., Clerget-Darpoux,F., Chartier-Harlin,M.-C. and the French Alzheimer's disease collaborative group (1995) Evidence for apolipoprotein E [epsis]4 association in early-onset alzheimer's patients with late-onset relatives. 

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Martinez,"

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Tardieu,"

Phrase: "S."

Phrase: ","

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Agid,Y.,"

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "Clerget-Darpoux,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Chartier-Harlin,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "the French Alzheimer's disease collaborative group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "(1995"

Phrase: ")"

Phrase: "Evidence for apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "[epsis"

Phrase: "]4 association in early-onset alzheimer's patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with late-onset relatives."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0080103:Relatives [Family Group]
   793 E C0205345:Relative [Qualitative Concept]
   793 E C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.213: Am. 

Phrase: "Am."
Processing 00000000.tx.214: J. 

Phrase: "J."
Processing 00000000.tx.215: Med. 

Phrase: "Med."
Processing 00000000.tx.216: Genet., 60, 550-553. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "60,"

Phrase: "550-553."
Processing 00000000.tx.217: MEDLINE Abstract 8. 

Phrase: "MEDLINE Abstract 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.218: Corder,E.H., Saunders,A.M., Strittmatter,W.J., Schmechel,D.E., Gaskell,P.C., Small,G.W., Roses,A.D., Haines,J.L and Pericak-Vance,M.A. 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L"

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.219: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late-onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.220: Science, 261, 921-923. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921-923."
Processing 00000000.tx.221: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.222: Corder,E.H., Saunders,A.M., Risch,N.J., Strittmatter,W.J., Schmechel,D.E., Gaskell,P.C., Rimmler,J.B., Locke,P.A., Conneally,P.M., Schmader,K.E., Small,G.W., Roses,A.D., Haines,J.L. and Pericak-Vance,M.A. 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Risch,"

Phrase: "N.J.,"

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Rimmler,"

Phrase: "J.B.,"

Phrase: "Locke,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Schmader,"

Phrase: "K.E.,"

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.223: (1994) Protective effect of apolipoprotein E type 2 for late-onset alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Protective effect of apolipoprotein E type 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "for late-onset alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.224: Nature Genet., 7, 180-184. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "180-184."
Processing 00000000.tx.225: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.226: Talbot,C., Lendon,C., Craddock,N., Morris,J.C. and Goate,A. 

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Craddock,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Morris,"

Phrase: "J.C."

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.227: (1994) Protection against Alzheimer's disease with APOE [epsis]2. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Protection against Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "with APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.228: Lancet, 343, 1432-1433. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "343,"

Phrase: "1432-1433."
Processing 00000000.tx.229: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.230: Strittmatter,W.J, Weisgraber,K.H., Huang,D.Y., Dong,L.-M., Salvesen,G.S., Pericak-Vance,M., Schmechel,D., Saunders,A.M., Goldgaber,D. and Roses,A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Salvesen,"

Phrase: "G.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.231: (1993) Binding of human apolipoprotein E to synthetic amyloid [beta] peptide: isoform-specific effects and implications for late-onset alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Binding of human apolipoprotein E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2247768:apolipoprotein binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to synthetic amyloid [beta] peptide"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   923   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   902   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ":"

Phrase: "isoform-specific effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "implications for late-onset alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.232: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.233: Natl. 

Phrase: "Natl."
Processing 00000000.tx.234: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.235: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.236: USA, 90, 8098-8102. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "8098-8102."
Processing 00000000.tx.237: MEDLINE Abstract 12. 

Phrase: "MEDLINE Abstract 12."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.238: Evans,K., Berger,E.P., Cho,C.G., Weisgraber,K.H. and Lansburry,P.T. 

Phrase: "Evans,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Berger,"

Phrase: "E.P.,"

Phrase: "Cho,C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lansburry,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.239: (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implication for the pathogenesis and treatment of Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a kinetic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0022702:kinetic [Natural Phenomenon or Process]
   944 E C0026597:Motion [Natural Phenomenon or Process]
   944 E C0687704:Motions [Functional Concept]
   928 E C0022699:Kineses [Individual Behavior]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a thermodynamic inhibitor of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "implication for the pathogenesis"

Phrase: "and"

Phrase: "treatment of Alzheimer's disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   881   C1979617:Alzheimer's disease treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.240: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.241: Natl. 

Phrase: "Natl."
Processing 00000000.tx.242: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.243: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.244: USA, 92, 763-767. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "92,"

Phrase: "763-767."
Processing 00000000.tx.245: MEDLINE Abstract 13. 

Phrase: "MEDLINE Abstract 13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.246: Miyata,M. and Smith,J.D. 

Phrase: "Miyata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J.D."
Processing 00000000.tx.247: (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and [beta]-amyloid peptides. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E allele-specific antioxidant activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C1325281:apolipoprotein activity [Molecular Function]
   827   C1148564:antioxidant activity [Molecular Function]
   799   C0003402:Antioxidant [Pharmacologic Substance]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "effects on cytotoxicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "by oxidative insults"

Phrase: "and ["

Phrase: "beta]-amyloid peptides."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.248: Nature Genet., 14, 55-60. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "14,"

Phrase: "55-60."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]
Processing 00000000.tx.249: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.250: Strittmatter,W.J., Weisgraber,K.H., Goedert,M., Saunders,A.M., Huang,D., Corder,E.H., Dong,L.-M., Jakes,R., Alberts,M.J., Gilbert,J.R., Han,S.H., Hulette,C., Einstein,G., Schmechel,D.E., Pericak-Vance,M.A. and Roses,A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huang,"

Phrase: "D."

Phrase: ","

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alberts,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Han,S.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Einstein,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.251: (1994) Hypothesis: microtubule instability and paired helical filament formation in Alzheimer disease are related to Apolipoprotein E genotype. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: ":"

Phrase: "microtubule instability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1444783:Instability [Finding]

Phrase: "and"

Phrase: "paired helical filament formation in Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "are"

Phrase: "related to Apolipoprotein E genotype."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.252: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.253: Neurology, 125, 163-171. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "125,"

Phrase: "163-171."
Processing 00000000.tx.254: 15. 

Phrase: "15."
Processing 00000000.tx.255: Van Duijn,C.M., De Knijff,P., Cruts,M., Wehnert,A., Havekes,L.M, Hofman,A. and Van Broeckhoven,C. 

Phrase: "Van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "De Knijff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Havekes,"

Phrase: "L.M,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.256: (1994) Apolipoprotein E4 allele in a population based study of early-onset alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E4 allele in a population based study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]

Phrase: "of early-onset alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.257: Nature Genet., 7, 74-78. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "74-78."
Processing 00000000.tx.258: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.259: Payami,H., Montee,K.R., Kaye,J.A., Bird,T.D., Yu,C.E., Wijsman,E.M. and Schellenberg,G.D. 

Phrase: "Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Montee,"

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kaye,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Wijsman,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.260: (1994) Alzheimer's disease, apolipoprotein E4, and gender. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "apolipoprotein E4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "gender."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]
Processing 00000000.tx.261: J. 

Phrase: "J."
Processing 00000000.tx.262: Am. 

Phrase: "Am."
Processing 00000000.tx.263: Med. 

Phrase: "Med."
Processing 00000000.tx.264: Assoc., 271, 1316-1317. 

Phrase: "Assoc.,"

Phrase: "271,"

Phrase: "1316-1317."
Processing 00000000.tx.265: 17. 

Phrase: "17."
Processing 00000000.tx.266: Van Duijn,C.M, Havekes,L.M., Van Broeckhoven,C., De Knijff,P. and Hofman,A. 

Phrase: "Van Duijn,"

Phrase: "C.M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Van Broeckhoven,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "De Knijff,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hofman,"

Phrase: "A."
Processing 00000000.tx.267: (1995) Apolipoprotein E genotype and association between smoking and early-onset alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "association between smoking"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "early-onset alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.268: Br. 

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.269: Med. 

Phrase: "Med."
Processing 00000000.tx.270: J., 310, 627-631. 

Phrase: "J.,"

Phrase: "310,"

Phrase: "627-631."
Processing 00000000.tx.271: 18. 

Phrase: "18."
Processing 00000000.tx.272: Jarvik,G.P., Wijsman,E.M., Kukull,W.A, Schellenberg,G.D., Yu,C. and Larson,E.B. 

Phrase: "Jarvik,"

Phrase: "G.P.,"

Phrase: "Wijsman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kukull,"

Phrase: "W."

Phrase: "A,"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C."

Phrase: "and"

Phrase: "Larson,"

Phrase: "E.B."
Processing 00000000.tx.273: (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age and sex in prediction of Alzheimer's disease: a case-control study. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Interactions of apolipoprotein E genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "total cholesterol level,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol level
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   901   C0543421:Total cholesterol [Steroid]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex in prediction of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009253:Sex [Organism Function]
   753   C0036864:Sex [Behavior]
   753   C0079399:sex [Organism Attribute]
   753   C1314687:Sex [Finding]
   753   C1522384:sex [Organism Attribute]

Phrase: ":"

Phrase: "a case-control study."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.274: Neurology, 45, 1092-1096. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "1092-1096."
Processing 00000000.tx.275: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.276: Wavrant-De Vrize,F., Prez-Tur,J., Lambert,J.-C., Frigard,B., Pasquier,F., Delacourte,A., Amouyel,P., Hardy,J. and Chartier-Harlin,M.-C. 

Phrase: "Wavrant-De Vrize,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.-C., Frigard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.277: (1997) Association between the low density lipoprotein-related receptor protein (LRP) and Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Association between the low density lipoprotein-related receptor protein (LRP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.278: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.279: Lett., 227, 68-70. 

Phrase: "Lett.,"

Phrase: "227,"

Phrase: "68-70."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]
Processing 00000000.tx.280: MEDLINE Abstract 20. 

Phrase: "MEDLINE Abstract 20."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.281: Helbecque,N., Richard,F., Cottel,D., Neuman,E., Guez,D. and Amouyel,P. 

Phrase: "Helbecque,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Richard,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cottel,"

Phrase: "D."

Phrase: ","

Phrase: "Neuman,"

Phrase: "E.,"

Phrase: "Guez,"

Phrase: "D."

Phrase: "and"

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.282: (1998) The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer's disease in a European Caucasian population, Alzheimer's disease and related disorders, in press. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The very low density lipoprotein (VLDL) receptor"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   937   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   937   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   884   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   840   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0442811:Very low [Finding]
   804   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0178587:density [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C0442824:Very [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1299352:Low [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "is"

Phrase: "a genetic susceptibility factor for Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "in a European Caucasian population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "related disorders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "in press."
Processing 00000000.tx.283: 21. 

Phrase: "21."
Processing 00000000.tx.284: Lambert,J-.C., Prez-Tur,J., Dupire,M.J., Galasko,D., Mann,D., Amouyel,P., Hardy,J., Delacourte,A. and Chartier-Harlin,M.-C. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J-.C., Prez-Tur,"

Phrase: "J.,"

Phrase: "Dupire,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Delacourte,"

Phrase: "A."

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.285: (1997) Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Distortion of allelic expression of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332482:Distortion [Anatomical Abnormality]
   748   C2919017:Distortion [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.286: Hum. 

Phrase: "Hum."
Processing 00000000.tx.287: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.288: Genet., 12, 2151-2154. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "2151-2154."
Processing 00000000.tx.289: 22. 

Phrase: "22."
Processing 00000000.tx.290: Mui,S., Briggs,M., Chung,H., Wallace,R.B., Gomez-Isla,T., Rebeck,G.W. and Hyman,B.T. 

Phrase: "Mui,"

Phrase: "S."

Phrase: ","

Phrase: "Briggs,"

Phrase: "M."

Phrase: ","

Phrase: "Chung,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "R.B.,"

Phrase: "Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rebeck,"

Phrase: "G.W."

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.291: (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with AD and strongly with the [epsis]4 allele. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A newly identified polymorphism in the apolipoprotein E enhancer gene region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0678951:gene polymorphism [Genetic Function]
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "strongly with the [epsis"

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.292: Neurology, 47, 196-201. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "47,"

Phrase: "196-201."
Processing 00000000.tx.293: MEDLINE Abstract 23. 

Phrase: "MEDLINE Abstract 23."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450348:23 [Quantitative Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.294: Hollenberg,S.M., Sternglanz,R., Cheng,P.F. and Weintraub,H. 

Phrase: "Hollenberg,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sternglanz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cheng,"

Phrase: "P.F."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.295: (1995) Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Identification of a new family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "of tissue-specific basic helix-loop-helix proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   907   C0288972:Basic Helix-Loop-Helix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with a two-hybrid system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0599647:Two Hybrid [Molecular Biology Research Technique]
Processing 00000000.tx.296: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.297: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.298: Biol., 15, 3813-3822. 

Phrase: "Biol.,"

Phrase: "15,"

Phrase: "3813-3822."
Processing 00000000.tx.299: MEDLINE Abstract 24. 

Phrase: "MEDLINE Abstract 24."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.300: Murre,C., McCaw,P.S. and Baltimore,D. 

Phrase: "Murre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Murre, NOS [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McCaw,"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.301: (1989) A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. 

Phrase: "(1989"

Phrase: ")"

Phrase: "A new DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "dimerization motif in immunoglobulin enhancer binding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514562:Motif [Amino Acid Sequence]

Phrase: "daughterless,"

Phrase: "MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "myc proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.302: Cell, 77, 451-459. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "77,"

Phrase: "451-459."
Processing 00000000.tx.303: 25. 

Phrase: "25."
Processing 00000000.tx.304: Shimizu,C., Akasawa,C., Nakanishi,S. and Kageyama,R. 

Phrase: "Shimizu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Akasawa,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kageyama,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.305: (1995) MATH-2, a mammalian helix-loop-helix factor structurally related to the product of drosophilia proneuronal gene atonal, is specifically expressed in the nervous system. 

Phrase: "(1995"

Phrase: ")"

Phrase: "MATH-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1422203:Math-2 [Gene or Genome]
   861   C0024934:Math [Occupation or Discipline]

Phrase: "a mammalian helix-loop-helix factor structurally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "related to the product of drosophilia proneuronal gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017337:Gene [Gene or Genome]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "atonal,"

Phrase: "is"

Phrase: "specifically"

Phrase: "expressed in the nervous system."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0027763:Nervous System [Body System]
   806   C0422837:NERVOUS SYSTEM [Finding]
   806   C1269560:Nervous system [Body System]
   760   C0027769:Nervous [Sign or Symptom]
   760   C0449913:System [Functional Concept]
   760   C0599851:Nervous [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   751 E C0205494:Neurologic [Qualitative Concept]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]
Processing 00000000.tx.306: Eur. 

Phrase: "Eur."
Processing 00000000.tx.307: J. 

Phrase: "J."
Processing 00000000.tx.308: Biochem., 229, 239-248. 

Phrase: "Biochem.,"

Phrase: "229,"

Phrase: "239-248."
Processing 00000000.tx.309: MEDLINE Abstract 26. 

Phrase: "MEDLINE Abstract 26."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.310: Akasawa,C., Izshibashi,M., Shimizu,C., Nakanishi,S. and Kageyama,R (1995) A mammalian helix-loop-helix factor structurally related to the product of drosophilia proneuronal gene atonal is a positive transcriptional regulator expressed in the developing nervous system. 

Phrase: "Akasawa,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Izshibashi,"

Phrase: "M."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kageyama,"

Phrase: "R (1995"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "A mammalian helix-loop-helix factor structurally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "related to the product of drosophilia proneuronal gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017337:Gene [Gene or Genome]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "atonal"

Phrase: "is"

Phrase: "a positive transcriptional regulator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040649:Transcriptional [Genetic Function]
   827   C0182953:REGULATOR [Medical Device]
   827   C1704734:Regulator [Medical Device]
   827   C1704735:Regulator [Conceptual Entity]

Phrase: "expressed in the developing nervous system."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   734 E C0205494:Neurologic [Qualitative Concept]
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: Biol. 

Phrase: "Biol."
Processing 00000000.tx.313: Chem., 270, 8730-8738. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "8730-8738."
Processing 00000000.tx.314: 27. 

Phrase: "27."
Processing 00000000.tx.315: Peyton,M., Stellrecht,C.M., Naya,F.J., Huang,H.P., Samora,P.J. and Tsai,M.J. 

Phrase: "Peyton,"

Phrase: "M."

Phrase: ","

Phrase: "Stellrecht,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Naya,"

Phrase: "F.J.,"

Phrase: "Huang,"

Phrase: "H.P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Samora,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Tsai,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.316: (1996) BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes. 

Phrase: "(1996"

Phrase: ")"

Phrase: "BETA3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420841:BETA3 [Gene or Genome]
  1000   C2698300:Beta3 [Gene or Genome]

Phrase: "a novel helix-loop-helix protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0282642:helix loop helix [Spatial Concept]

Phrase: "can"

Phrase: "act as a negative regulator of BETA2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0182953:REGULATOR [Medical Device]
   748   C0205160:Negative [Qualitative Concept]
   748   C1417683:BETA2 [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
   748   C1823554:Beta2 [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   748   C3273872:BETA2 [Gene or Genome]

Phrase: "and"

Phrase: "MyoD-responsive genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.317: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.318: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.319: Biol., 16, 626-633. 

Phrase: "Biol.,"

Phrase: "16,"

Phrase: "626-633."
Processing 00000000.tx.320: MEDLINE Abstract 28. 

Phrase: "MEDLINE Abstract 28."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.321: Caudy,M., Vssin,H., Brand,M., Tuma,R., Jan,L.Y. and Jan,Y.N. 

Phrase: "Caudy,"

Phrase: "M."

Phrase: ","

Phrase: "Vssin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Brand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0645690:BrAnd [Pharmacologic Substance,Steroid]

Phrase: "M."

Phrase: ","

Phrase: "Tuma,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jan,L.Y."

Phrase: "and"

Phrase: "Jan,Y.N."
Processing 00000000.tx.322: (1988) Daughterless, a drosophilia gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Daughterless,"

Phrase: "a drosophilia gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "essential for both neurogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "sex determination,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0036871:sex determination [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C1367886:Sex determination [Biologic Function]
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0079399:sex [Organism Attribute]
   861   C1148554:determination [Laboratory Procedure]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "has"

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "similarities to myc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "the achaete-scute complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0222044:Scute [Body Part, Organ, or Organ Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.323: Cell, 55, 1061-1067. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "1061-1067."
Processing 00000000.tx.324: MEDLINE Abstract 29. 

Phrase: "MEDLINE Abstract 29."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.325: American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. 

Phrase: "American Psychiatric Association"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "(1987"

Phrase: ")"

Phrase: "Diagnostic and statistical manual of mental disorders."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]
Processing 00000000.tx.326: Third edition revised (DMS-III-R) American Psychatric Association (ed.) 

Phrase: "Third edition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441796:Third edition [Intellectual Product]
   861   C0441792:Edition [Intellectual Product]

Phrase: "revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "(DMS-III-R) American Psychatric Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0004083:Association [Mental Process]
   799   C0439849:Association [Qualitative Concept]
   799   C0596306:Association [Phenomenon or Process]
   799   C0699792:association [Social Behavior]

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"
Processing 00000000.tx.327: Washington DC. 

Phrase: "Washington DC."
Processing 00000000.tx.328: 30. 

Phrase: "30."
Processing 00000000.tx.329: McKahn,G., Drachman,D., Folstein,M., Karzman,R., Price,D. and Stadlan,E. 

Phrase: "McKahn,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Karzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E."
Processing 00000000.tx.330: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA work group. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRA work group."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]
Processing 00000000.tx.331: Neurology, 34, 939-944. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.332: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.333: Hixon,J.E. and Vernier,D.T. 

Phrase: "Hixon,"

Phrase: "J.E."

Phrase: "and"

Phrase: "Vernier,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.334: (1991) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Restriction isotyping of human apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by gene amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017256:Gene Amplification [Genetic Function]
  1000   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   861   C0017337:Gene [Gene or Genome]
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]

Phrase: "and"

Phrase: "cleavage with HhaI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
Processing 00000000.tx.335: J. 

Phrase: "J."
Processing 00000000.tx.336: Lipid Res., 31, 545-548. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "545-548."
Processing 00000000.tx.337: 32. 

Phrase: "32."
Processing 00000000.tx.338: Bickbller,H., Campion,D., Brice,A., Amouyel,P., Hannequin,D., Didierjean,O., Penet,C., Martin,C., Prez-Tur,J., Michon,A., Dubois,B., Ledoez,F., Thomas-Anterion,C., Pasquier,F., Puel,M., Demonet,J.F., Moreaud,O., Babron,M.C., Meulien,D., Guez,D., Chartier-Harlin,M.-C., Frebourg,T., Agid,Y., Martinez,M. and Clerget-Darpoux,F. 

Phrase: "Bickbller,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Michon,"

Phrase: "A.,"

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ledoez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Thomas-Anterion,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Puel,"

Phrase: "M."

Phrase: ","

Phrase: "Demonet,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Moreaud,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Babron,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Meulien,"

Phrase: "D."

Phrase: ","

Phrase: "Guez,"

Phrase: "D."

Phrase: ","

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Frebourg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Agid,Y.,"

Phrase: "Martinez,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Clerget-Darpoux,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.339: (1997) Apolipoprotrein E and Alzheimer disease: genotype-specific risks by age and sex. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Apolipoprotrein E"

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "genotype-specific risks by age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risks [Qualitative Concept]

Phrase: "and"

Phrase: "sex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]
Processing 00000000.tx.340: Am. 

Phrase: "Am."
Processing 00000000.tx.341: J. 

Phrase: "J."
Processing 00000000.tx.342: Hum. 

Phrase: "Hum."
Processing 00000000.tx.343: Genet., 60, 439-446. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "60,"

Phrase: "439-446."
Processing 00000000.tx.344: 33. 

Phrase: "33."
Processing 00000000.tx.345: The APOE and Alzheimer disease meta analysis consortium (1997) Effects of age, gender and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. 

Phrase: "The APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease meta analysis consortium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1513822:Consortium [Professional or Occupational Group]
   804   C1880171:Consortium [Professional or Occupational Group]

Phrase: "(1997"

Phrase: ")"

Phrase: "Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: Am. 

Phrase: "Am."
Processing 00000000.tx.348: Med. 

Phrase: "Med."
Processing 00000000.tx.349: Assoc., 278, 1349-1356. 

Phrase: "Assoc.,"

Phrase: "278,"

Phrase: "1349-1356."
Processing 00000000.tx.350: 34. 

Phrase: "34."
Processing 00000000.tx.351: Hill,W.G. 

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "W.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.352: (1975) Tests for association of gene frequencies at several loci in random mating diploid populations. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Tests for association of gene frequencies"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0017270:Gene Frequencies [Quantitative Concept]
   753   C0004083:Association [Mental Process]
   753   C0017337:Gene [Gene or Genome]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:Tests [Intellectual Product]
   753   C0439603:Frequencies [Temporal Concept]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "at several loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "in random mating diploid populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]
Processing 00000000.tx.353: Biometrics, 31, 881-888. 

Phrase: "Biometrics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2718322:Biometrics [Occupation or Discipline]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "881-888."
Processing 00000000.tx.354: MEDLINE Abstract 35. 

Phrase: "MEDLINE Abstract 35."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.355: Thompson,E.A., Deeb,S., Walker,D. and Motuslsky,A.G. 

Phrase: "Thompson,"

Phrase: "E.A.,"

Phrase: "Deeb,"

Phrase: "S."

Phrase: ","

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D."

Phrase: "and"

Phrase: "Motuslsky,"

Phrase: "A.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.356: (1988) The detection of linkage disequilibrium between closely markers: RFLPs at the AI-CIII apolipoprotein genes. 

Phrase: "(1988"

Phrase: ")"

Phrase: "The detection of linkage disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "between closely markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: ":"

Phrase: "RFLPs at the AI-CIII apolipoprotein genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035268:RFLPs [Clinical Attribute]
Processing 00000000.tx.357: Am. 

Phrase: "Am."
Processing 00000000.tx.358: J. 

Phrase: "J."
Processing 00000000.tx.359: Hum. 

Phrase: "Hum."
Processing 00000000.tx.360: Genet., 42, 113-124. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "42,"

Phrase: "113-124."
Processing 00000000.tx.361: MEDLINE Abstract 36. 

Phrase: "MEDLINE Abstract 36."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.362: Mc Lean,C.J. and Morton,N.E. 

Phrase: "Mc Lean,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Morton,"

Phrase: "N.E."
Processing 00000000.tx.363: (1985) Efficiency of lod scores for representing multiple locus linkage data. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Efficiency of lod scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:Efficiency [Quantitative Concept]

Phrase: "for representing multiple locus linkage data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]
Processing 00000000.tx.364: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.365: Epidemiol., 2, 263-272. 

Phrase: "Epidemiol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "263-272."
Processing 00000000.tx.366: 37. 

Phrase: "37."
Processing 00000000.tx.367: Cox,N.J., Bell,G.I. and Xiang,K.S. 

Phrase: "Cox,N.J.,"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Xiang,"

Phrase: "K.S."
Processing 00000000.tx.368: (1988) Linkage disequilibrium in the human insulin/insulin-like growth factor II region of human chromosome II. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Linkage disequilibrium in the human insulin/insulin-like growth factor II region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0023746:Linkage Disequilibrium [Quantitative Concept]
   736   C0023745:linkage [Molecular Function]
   736   C0281825:Disequilibrium [Finding]
   736   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "of human chromosome II."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0008643:Human Chromosome [Cell Component]
Processing 00000000.tx.369: Am. 

Phrase: "Am."
Processing 00000000.tx.370: J. 

Phrase: "J."
Processing 00000000.tx.371: Hum. 

Phrase: "Hum."
Processing 00000000.tx.372: Genet., 42, 495-501. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "42,"

Phrase: "495-501."
Processing 00000000.tx.373: 38. 

Phrase: "38."
Processing 00000000.tx.374: Benlian,P., Boileau,C., Loux,N., Pastier,D., Masliah,J., Coulon,M., Nigou,M., Ragab,A., Guimard,J., Ruidavets,J.B., Bonat-Pelli,C., Fruchart,J.C., Douste-Blazy,P., Bereziat,G. and Junien,C. 

Phrase: "Benlian,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Boileau,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Loux,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pastier,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   916   C0030634:Pastes [Substance]
   916   C1321899:Paste [Biomedical or Dental Material]
   916   C3205672:Pastes [Pharmacologic Substance]
   900 E C0452694:Pasta [Food]

Phrase: "D."

Phrase: ","

Phrase: "Masliah,"

Phrase: "J.,"

Phrase: "Coulon,"

Phrase: "M."

Phrase: ","

Phrase: "Nigou,"

Phrase: "M."

Phrase: ","

Phrase: "Ragab,"

Phrase: "A.,"

Phrase: "Guimard,"

Phrase: "J.,"

Phrase: "Ruidavets,"

Phrase: "J.B.,"

Phrase: "Bonat-Pelli,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fruchart,"

Phrase: "J.C., Douste-Blazy,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bereziat,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Junien,"

Phrase: "C."
Processing 00000000.tx.375: (1991) Extended haplotypes and linkage disequilibrium between II markers at the APOAI-C3-C4-A4 gene cluster on chromosome II. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Extended haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "linkage disequilibrium between II markers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "at the APOAI-C3-C4-A4 gene cluster"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017258:Gene cluster [Gene or Genome]
   799   C1555715:Cluster [Idea or Concept]
   799   C1704332:Cluster [Quantitative Concept]
   709   C1412468:APOA1 gene [Gene or Genome]

Phrase: "on chromosome II."
Processing 00000000.tx.376: Am. 

Phrase: "Am."
Processing 00000000.tx.377: J. 

Phrase: "J."
Processing 00000000.tx.378: Hum. 

Phrase: "Hum."
Processing 00000000.tx.379: Genet., 48, 903-910. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "48,"

Phrase: "903-910."
Processing 00000000.tx.380: MEDLINE Abstract *To whom correspondence should be addressed. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.381: Tel: +33 3 20 87 77 10; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+33 3 20 87 77 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C1630409:20/10 [Finding]

Phrase: ";"
Processing 00000000.tx.382: Fax: +33 3 20 87 78 94; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+33 3 20 87 78 94"

Phrase: ";"
Processing 00000000.tx.383: Email: philippe.amouyel@pasteur-lille.fr This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk Last modification: 14 Feb 1998 Copyright Oxford University Press, 1998.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "philippe.amouyel@pasteur-lille.fr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2348513:Fr. [Conceptual Entity]
   804   C3538902:FR [Gene or Genome]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "www-admin{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "14 Feb 1998 Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0041740:University [Manufactured Object,Organization]

Phrase: "1998."

